Zoster [herpes zoster]

AB1_ZOSTER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B02
  • Hospital discharge: ICD-9 05[3]
  • Hospital discharge: ICD-8 05[3]
  • Cause of death: ICD-10 B02
  • Cause of death: ICD-9 05[3]
  • Cause of death: ICD-8 05[3]

2 out of 7 registries used, show all original rules.

7397

4. Check minimum number of events

None

7397

5. Include endpoints

None

7397

6. Filter based on genotype QC (FinnGen only)

7397

Control definitions (FinnGen only)

Control exclude
AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 58464 34906 23029
Only index persons 47995 29009 18986
Unadjusted period prevalence (%)
Whole population 0.86 1.00 0.64
Only index persons 0.93 1.07 0.72
Median age at first event (years)
Whole population 68.79 70.21 66.69
Only index persons 67.63 69.09 65.40

-FinnGen-

Key figures

All Female Male
Number of individuals 7397 4353 3044
Unadjusted period prevalence (%) 1.43 1.48 1.34
Median age at first event (years) 66.13 64.57 68.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
6522
Matched controls
65220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B02.9
ICD-10 Finland
Zoster without complication
139.0
323.0
4545
1059
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
4470.7
323.0
429
*
S01AD03
ATC
aciclovir; ophthalmic
14.9
323.0
984
770
B02
ICD-10 Finland
Zoster [herpes zoster]
9.2
323.0
777
947
B02.8
ICD-10 Finland
Zoster with other complications
108.4
323.0
435
43
J05AB01
ATC
aciclovir; systemic
8.1
323.0
3398
7680
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
1215.5
323.0
453
*
B02.3
ICD-10 Finland
Zoster ocular disease
525.8
323.0
350
7
J05AB11
ATC
valaciclovir; oral
12.6
323.0
2987
4101
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
+∞
196.8
188
*
G53.0
ICD-10 Finland
Postzoster neuralgia
27.1
188.0
263
101
N03AX16
ATC
pregabalin; oral
2.4
175.1
1920
9692
S70
ICPC
Herpes zoster
7.0
156.6
408
616
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
144.3
138
*
H02AB06
ATC
prednisolone; systemic
1.9
139.6
3261
22180
127
Kela drug reimbursment
Transplant complication
12.1
137.3
258
221
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
687.5
137.2
135
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
134.6
3094
20814
N03AX12
ATC
gabapentin; oral
2.5
134.2
1251
5681
N02AX02
ATC
tramadol; systemic, rectal
1.9
128.6
2947
19684
0539X
ICD-9 Finland
Herpes zoster without mention of complication
+∞
120.2
115
*
L04AA06
ATC
mycophenolic acid; systemic
9.5
117.3
250
273
B02.0
ICD-10 Finland
Zoster encephalitis
573.0
114.3
113
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
113.7
480
1247
R50.9
ICD-10 Finland
Fever, unspecified
2.4
111.4
1089
5019
L04AX01
ATC
azathioprine; systemic
4.2
103.9
425
1071
G53.0*B02.21
ICD-10 Finland
Postherpetic geniculate ganglionitis
177.8
100.6
105
6
J01DB01
ATC
cefalexin; oral
1.9
94.7
5150
43573
L04AD01
ATC
ciclosporin; systemic
7.2
94.4
239
344
A02BC02
ATC
pantoprazole; systemic
1.7
90.4
4139
32871
N02BE01
ATC
paracetamol; systemic, rectal
1.9
87.2
5508
48087
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
85.1
2342
15925
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
829.0
83.7
82
*
A46
ICD-10 Finland
Erysipelas
2.1
82.6
1044
5361
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
82.4
526
1874
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
82.1
863
4072
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
81.0
393
1144
B00.10
ICD-10 Finland
Herpes simplex facialis
18.2
79.4
125
70
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
202.4
77.4
80
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
77.3
532
1987
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
74.2
2722
19854
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
72.6
933
4802
L04AA01
ATC
[U] ciclosporin; systemic
6.7
70.7
187
287
B00.5
ICD-10 Finland
Herpesviral ocular disease
149.7
70.1
74
5
N02AA05
ATC
oxycodone; systemic
2.0
69.9
1089
6046
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
68.2
1634
10493
ZX120
NOMESCO Finland
Intravenous
2.3
68.0
697
3230
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
67.2
1899
12791
L03AA02
ATC
filgrastim; parenteral
4.1
66.9
272
679
05306
ICD-8 Finland
Herpes zoster, Alius
+∞
66.8
64
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.1
65.0
787
3935
H02AB04
ATC
methylprednisolone; systemic
1.9
64.8
1018
5654
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
64.3
1368
8439
B02.20
ICD-10 Finland
Herpes zoster trigeminal neuralgia
81.0
64.1
72
9
H62.1*B02.8
ICD-10 Finland
Otitis externa in zoster
320.2
63.5
64
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
63.0
1082
6202
C03CA01
ATC
furosemide; systemic
1.6
62.4
2084
14631
R51.80
ICD-10 Finland
Headache
2.0
62.3
910
4910
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
62.1
2152
15249
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
112.8
61.9
67
6
Z94.0
ICD-10 Finland
Kidney transplant status
8.9
61.0
133
152
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
60.5
454
1777
J01MA12
ATC
levofloxacin; systemic
1.8
56.3
1215
7487
R06.0
ICD-10 Finland
Dyspnoea
1.7
56.2
1621
10875
WW200
NOMESCO Finland
Immunization
4.0
55.9
238
619
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
55.6
1373
8811
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.3
54.7
287
886
G530, B028
ICD-10 Finland
NA
+∞
54.2
52
*
H02AB09
ATC
hydrocortisone; systemic
4.2
52.5
206
497
G63.0*B02.29
ICD-10 Finland
Postherpetic polyneuropathy
268.0
52.2
53
*
J01FF01
ATC
clindamycin; systemic
1.6
51.9
1621
11067
05300
ICD-8 Finland
Herpes zoster, Opthalmicus
+∞
51.1
49
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
50.7
2326
17414
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
50.6
2117
15518
B02.7
ICD-10 Finland
Disseminated zoster
257.4
50.1
51
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
49.5
2230
16602
M04AA01
ATC
allopurinol; systemic
1.8
48.4
886
5149
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
48.1
1040
6377
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
47.7
330
1230
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
47.4
594
2994
B07.9
ICD-10 Finland
Verruca simplex
4.2
46.9
185
449
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
46.7
641
3351
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
46.0
1682
11881
AA1AD
NOMESCO Finland
CT of head and brain
1.6
45.8
1510
10399
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
45.5
2659
20820
H02AB07
ATC
prednisone; oral
1.8
45.3
939
5674
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
44.9
1294
8597
H03.1
ICD-10 Finland
Involvement of eyelid in other infectious diseases classified elsewhere
30.3
44.8
60
20
M79.6
ICD-10 Finland
Pain in limb
1.5
44.8
2093
15618
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.8
44.4
97
112
J01MA02
ATC
ciprofloxacin; systemic
1.5
44.2
2379
18284
UJF32
NOMESCO Finland
Coloscopy
1.6
44.0
1610
11353
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
43.5
654
3536
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
13.2
43.5
77
59
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
15.7
42.5
70
45
WW500
NOMESCO Finland
Blood transfusion
2.7
42.5
300
1132
SPAT1263
SPAT
Sampling
1.5
42.3
2561
20098
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.1
42.1
81
74
J01AA02
ATC
doxycycline; systemic
1.5
41.7
4685
41388
B02.29
ICD-10 Finland
Herpes zoster polyneuropathy
+∞
41.7
40
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
41.3
2521
19788
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
41.3
1111
7226
E0000UV
ATC
NA
1.5
41.2
2287
17615
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
40.2
950
5953
Z3231
NOMESCO Finland
Registered nurse
1.5
40.1
1652
11923
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.7
40.1
295
1137
M54.5
ICD-10 Finland
Low back pain
1.5
39.8
1826
13493
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
39.8
977
6190
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
39.5
893
5522
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
39.4
1149
7625
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
39.3
465
2282
R42
ICD-10 Finland
Dizziness and giddiness
1.6
38.8
1378
9601
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
38.6
1565
11239
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
38.5
1034
6708
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
38.4
184
531
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
38.1
1061
6949
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
37.6
870
5413
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
37.4
2182
16881
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.5
37.4
183
537
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
37.1
402
1895
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
37.0
682
3949
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
37.0
423
2044
J01MA14
ATC
moxifloxacin; systemic
1.9
37.0
553
2976
R03AC02
ATC
salbutamol; inhalant
1.4
36.7
2966
24349
TGC00
NOMESCO Finland
Bronchial lavation
3.2
36.5
203
655
B02.21
ICD-10 Finland
Herpes zoster neuralgia in another cranial nerve
38.6
36.5
46
12
A02BC01
ATC
omeprazole; systemic
1.5
36.4
1705
12604
A02BC05
ATC
esomeprazole; systemic
1.4
36.3
2359
18604
WX110
NOMESCO Finland
Local anesthesy
1.4
36.0
3849
33145
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
35.9
333
1458
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.9
35.9
83
106
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
35.7
600
3367
JN4BD
NOMESCO Finland
Extensive body CT
1.8
35.7
702
4151
P01BA02
ATC
hydroxychloroquine; oral
2.0
35.6
513
2724
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.1
35.5
115
229
S18
ICPC
Laceration/cut
1.4
35.5
2456
19563
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
35.3
1017
6707
ZX108
NOMESCO Finland
Inhalation
7.4
35.2
85
116
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
34.8
218
763
TK800
NOMESCO Finland
Hemodialysis
3.5
34.6
165
475
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
34.6
373
1756
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
34.5
1231
8553
A07AA02
ATC
nystatin; oral
2.0
34.2
438
2218
A04AA01
ATC
ondansetron; systemic, rectal
2.1
34.0
422
2111
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
33.7
424
2130
R4110
NOMESCO Finland
Physiotherapy
1.5
33.7
1543
11316
TAB00
NOMESCO Finland
Lumbar puncture
2.5
33.4
268
1085
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
33.1
1017
6806
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
12.7
32.9
59
47
137
Kela drug reimbursment
Uraemia requiring dialysis
6.4
32.9
88
139
D06BB03
ATC
aciclovir; topical
2.3
32.9
318
1422
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13.4
32.6
57
43
Z2446
NOMESCO Finland
Social worker
2.1
32.5
404
2021
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
32.4
1842
14085
B01.9
ICD-10 Finland
Varicella without complication
27.7
32.3
44
16
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
32.3
31
*
M05BA04
ATC
alendronic acid; oral
1.8
32.1
587
3385
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
32.1
656
3920
A11CC03
ATC
alfacalcidol; systemic
3.2
32.0
174
554
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
31.9
548
3094
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
31.9
219
813
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
31.7
2764
22774
R53
ICD-10 Finland
Malaise and fatigue
1.5
31.6
1228
8675
C07AB07
ATC
bisoprolol; oral
1.4
31.5
2901
24111
N06AA09
ATC
amitriptyline; systemic
1.8
31.5
627
3713
R06AE07
ATC
cetirizine; oral
1.4
31.5
2396
19286
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.4
30.8
82
129
05309
ICD-8 Finland
Herpes zoster, Unspecified
+∞
30.2
29
*
0538X
ICD-9 Finland
Herpes zoster, With unspecified complication[HERPES ZOSTER ALIUS DEFINITUS]
+∞
30.2
29
*
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
30.2
29
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.1
30.0
60
60
WW409
NOMESCO Finland
Other aferesis
18.5
30.0
46
25
SPAT1301
SPAT
No procedures
1.4
30.0
1896
14743
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
14.8
29.9
50
34
J01CA04
ATC
amoxicillin; systemic
1.4
29.6
4660
42036
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
29.6
506
2852
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
9.8
29.5
60
62
ZXD05
NOMESCO Finland
Urgent procedure
1.4
29.4
1756
13500
L03AA13
ATC
pegfilgrastim; parenteral
2.4
29.2
257
1094
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
29.2
254
1076
A07EC01
ATC
sulfasalazine; oral, rectal
1.9
29.1
461
2530
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
29.0
678
4208
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
29.0
1680
12839
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
29.0
805
5238
R60.0
ICD-10 Finland
Localized oedema
1.7
28.9
685
4268
L28
ICPC
Limited function/disability (L)
1.5
28.7
991
6803
R11
ICD-10 Finland
Nausea and vomiting
1.8
28.3
488
2753
B03XA01
ATC
erythropoietin; parenteral
5.3
28.2
87
165
JN4AD
NOMESCO Finland
Body CT examination
1.9
28.2
457
2524
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
28.2
1791
13904
B05DA
ATC
Isotonic solutions
7.2
28.2
69
97
B02.1
ICD-10 Finland
Zoster meningitis
+∞
28.1
27
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
28.1
1466
10970
SPAT1153
SPAT
Removal of sutures
1.4
27.8
1853
14496
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
27.6
433
2366
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
27.6
476
2690
D07AA02
ATC
hydrocortisone; topical
1.6
27.5
747
4830
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
27.3
1018
7102
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
38.0
27.0
34
9
L01BB05
ATC
fludarabine; systemic
23.9
26.9
38
16
R52.9
ICD-10 Finland
Pain, unspecified
1.8
26.8
479
2737
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
26.6
533
3161
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
26.4
1073
7620
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
26.2
337
1706
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
26.2
596
3670
J01FA06
ATC
roxithromycin; oral
1.3
26.1
2276
18565
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
26.1
872
5926
Z71.8
ICD-10 Finland
Other specified counselling
1.4
26.1
1247
9156
G02.0*B02.1
ICD-10 Finland
Zoster meningitis
+∞
26.1
25
*
G51.0
ICD-10 Finland
Bell palsy
2.8
25.9
174
637
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
25.7
387
2083
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
25.7
647
4092
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.3
25.7
240
1056
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
25.7
854
5797
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
25.6
341
1752
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
25.6
1543
11831
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
25.5
530
3175
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
25.5
2077
16744
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
25.4
850
5779
B01AB05
ATC
enoxaparin; parenteral
1.4
25.3
1750
13731
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
25.3
451
2571
H57.1
ICD-10 Finland
Ocular pain
2.6
25.3
184
709
N06AX21
ATC
duloxetine; oral
1.7
25.2
567
3475
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.0
25.2
316
1586
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
25.0
2227
18189
P01AB01
ATC
metronidazole; oral, rectal
1.3
25.0
2129
17272
ZXE00
NOMESCO Finland
One hour or less
1.3
25.0
2217
18105
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.7
24.9
112
309
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.9
24.8
70
120
N05CF01
ATC
zopiclone; oral
1.4
24.8
1893
15089
J02AC01
ATC
fluconazole; systemic
1.3
24.7
2072
16763
C90.0
ICD-10 Finland
Multiple myeloma
4.1
24.7
97
238
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
24.6
187
739
J01DA01
ATC
[U] cefalexin; systemic
1.3
24.6
3606
31655
B03XA02
ATC
darbepoetin alfa; parenteral
3.1
24.5
136
441
SPAT1262
SPAT
Handing over of treatment supplies
1.5
24.5
1030
7360
D07AC01
ATC
betamethasone; topical
1.4
24.4
1870
14903
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.4
24.2
120
358
WX002
NOMESCO Finland
Sedation and analgesia
1.4
24.1
1143
8366
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.0
24.0
98
249
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
23.8
522
3177
SPAT1312
SPAT
General health counselling
1.4
23.7
1769
14024
S29
ICPC
Skin symptom/complaint other
1.5
23.6
938
6614
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
23.6
260
1236
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
23.4
891
6227
ZXA00
NOMESCO Finland
Right side
1.4
23.3
1577
12300
H02AB02
ATC
dexamethasone; systemic
1.6
23.0
582
3681
TQW80
NOMESCO Finland
Local dermatologic skincare
2.6
22.8
169
660
SPAT1254
SPAT
Administration of medicine
1.5
22.7
893
6284
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.4
22.5
83
192
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
22.5
430
2508
SPAT1325
SPAT
Vaccination
1.3
22.5
2049
16725
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.1
22.5
258
1249
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.8
22.4
151
557
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.7
22.4
156
588
A12AA04
ATC
calcium carbonate; oral
3.3
22.3
112
339
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
22.2
579
3694
M03BX02
ATC
tizanidine; oral
1.3
22.2
3238
28215
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
22.2
526
3270
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
22.1
165
647
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
22.0
301
1563
S01
ICPC
Pain/tenderness of skin
2.1
22.0
254
1231
H26.3
ICD-10 Finland
Drug-induced cataract
7.2
21.9
53
74
H16.0
ICD-10 Finland
Corneal ulcer
2.1
21.6
243
1166
Z49.2
ICD-10 Finland
Other dialysis
6.2
21.6
58
94
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.5
21.6
77
173
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
21.5
1925
15646
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.5
21.5
171
695
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
5.1
21.4
68
135
N03AF01
ATC
carbamazepine; oral, rectal
1.9
21.3
312
1664
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
21.2
160
631
B05DB
ATC
Hypertonic solutions
6.5
21.2
55
85
C08CA01
ATC
amlodipine; oral
1.3
21.2
2079
17121
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
21.1
438
2619
A01
ICPC
Pain general/multiple sites
1.7
21.1
443
2659
Z3226
NOMESCO Finland
Physiotherapist
1.4
21.1
1023
7500
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
21.0
224
1051
B01AA03
ATC
warfarin; systemic
1.4
20.9
1241
9434
B02.2
ICD-10 Finland
Zoster with other nervous system involvement
60.2
20.9
24
*
H13.1*B00.5
ICD-10 Finland
Herpesviral conjunctivitis
+∞
20.8
20
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.0
20.8
291
1522
R07.3
ICD-10 Finland
Other chest pain
1.6
20.6
517
3263
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.4
20.6
75
172
ZXA10
NOMESCO Finland
Bilateral
1.4
20.6
1084
8065
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
20.6
287
1501
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
20.6
419
2493
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
20.6
672
4533
SPAT1310
SPAT
Counselling related to known health issue
1.3
20.6
1748
14083
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
20.5
434
2609
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.7
20.5
139
515
A06AD11
ATC
lactulose; oral
1.5
20.5
886
6350
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
20.5
662
4454
A02BC03
ATC
lansoprazole; oral
1.3
20.2
1651
13214
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
20.2
270
1392
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.4
20.2
99
295
V03AE02
ATC
sevelamer; oral
7.3
20.1
48
66
H01.0
ICD-10 Finland
Blepharitis
2.0
20.1
275
1428
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
20.1
1079
8057
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
20.0
1911
15642
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
20.0
352
1998
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
17.3
20.0
31
18
N30.0
ICD-10 Finland
Acute cystitis
1.5
19.9
808
5715
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
19.8
449
2753
J01FA10
ATC
azithromycin; systemic
1.3
19.7
3006
26175
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
19.7
395
2340
V03AE01
ATC
polystyrene sulfonate; oral
3.5
19.6
92
265
SPAT1260
SPAT
Consultation of another employee
1.4
19.6
996
7359
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
19.4
551
3589
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
19.4
940
6879
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
19.3
583
3855
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.1
19.3
109
360
S97
ICPC
Chronic ulcer skin
1.8
19.2
316
1757
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.6
19.2
31
20
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
19.2
213
1017
Z00.0
ICD-10 Finland
General medical examination
1.4
19.2
984
7281
SPAT1255
SPAT
Intravenous administration of medicine
1.7
19.1
371
2173
D07AC13
ATC
mometasone; topical
1.3
19.1
1520
12097
6BA02
NOMESCO Finland
NA
9.3
19.0
39
42
R55
ICD-10 Finland
Syncope and collapse
1.5
19.0
628
4244
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
19.0
223
1091
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
18.9
1389
10912
H22.0
ICD-10 Finland
Iridocyclitis in infectious and parasitic diseases classified elsewhere
55.2
18.9
22
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.6
18.9
85
237
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
34.4
18.9
24
7
H16.9
ICD-10 Finland
Keratitis, unspecified
3.2
18.8
98
306
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
18.8
643
4376
G44.2
ICD-10 Finland
Tension-type headache
1.5
18.8
660
4522
ZXA05
NOMESCO Finland
Left side
1.3
18.7
1457
11555
L17
ICPC
Foot/toe symptom/complaint
1.3
18.7
1347
10553
N18.0
ICD-10 Finland
End-stage renal disease
3.5
18.6
88
256
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
9.3
18.5
38
41
ZX112
NOMESCO Finland
Subcutaneous
2.6
18.5
139
548
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.1
18.5
224
1108
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
18.5
258
1352
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
18.5
508
3283
K02.1
ICD-10 Finland
Caries of dentine
1.3
18.4
2841
24699
M25.5
ICD-10 Finland
Pain in joint
1.3
18.4
1414
11183
A02BA02
ATC
ranitidine; systemic
1.4
18.3
1139
8708
L57.0
ICD-10 Finland
Actinic keratosis
1.5
18.3
574
3834
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.8
18.2
61
129
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.1
18.2
102
336
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
18.1
607
4112
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
18.1
394
2392
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
9.8
18.1
36
37
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.6
18.1
129
495
L01AA01
ATC
cyclophosphamide; systemic
5.8
18.0
51
89
SPAT1211
SPAT
Application of soft bandage
1.6
17.9
505
3284
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
17.9
877
6427
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
13.0
17.9
31
24
1XC02
NOMESCO Finland
NA
4.3
17.8
65
151
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.4
17.7
46
72
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
17.7
1216
9442
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
17.7
1198
9284
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.5
17.6
134
533
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
17.6
406
2502
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
13.1
17.4
30
23
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
17.4
887
6548
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
17.3
756
5415
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.5
17.3
51
94
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.6
17.3
123
470
N18.8
ICD-10 Finland
Other chronic renal failure
2.2
17.2
177
818
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
17.2
1734
14242
M79.1
ICD-10 Finland
Myalgia
1.5
17.2
642
4452
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
17.2
1420
11337
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
17.2
287
1606
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
17.1
779
5624
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.8
17.1
110
396
D07AB08
ATC
desonide; topical
1.5
17.1
547
3668
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
6.7
17.0
43
65
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
8.0
17.0
38
48
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
16.9
404
2517
H01
ICPC
Ear pain/earache
1.6
16.9
499
3280
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
16.9
328
1923
L01BB02
ATC
mercaptopurine; oral
4.4
16.9
61
140
L04AA13
ATC
leflunomide; oral
2.4
16.9
147
626
A07EA06
ATC
budesonide; oral, local oral
2.1
16.8
182
862
J02AC03
ATC
voriconazole; systemic
12.0
16.8
30
25
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
16.8
384
2362
Z85.6
ICD-10 Finland
Personal history of leukaemia
63.5
16.7
19
*
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
16.7
340
2022
0532A
ICD-9 Finland
Herpes zoster, With ophthalmic complications[HERPES ZOSTER PALPEBRAE OCULI]
+∞
16.7
16
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
16.7
279
1562
L01BB01
ATC
NA
8.8
16.6
35
40
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
9.7
16.6
33
34
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
9.7
16.6
33
34
A05AA02
ATC
ursodeoxycholic acid; oral
2.9
16.5
99
342
N05BA04
ATC
oxazepam; oral
1.3
16.5
1323
10506
A98
ICPC
Health maint/preventive medicine
1.4
16.5
5763
55139
WZC30
NOMESCO Finland
Teaching
1.5
16.4
679
4810
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
5.1
16.4
51
100
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
8.2
16.4
36
44
R05
ICD-10 Finland
Cough
1.4
16.4
998
7590
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
16.4
364
2220
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.6
16.3
73
204
G47.3
ICD-10 Finland
Sleep apnoea
1.4
16.3
973
7375
C10AA05
ATC
atorvastatin; oral
1.3
16.3
2124
18005
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
16.2
956
7227
Z2221
NOMESCO Finland
Medical doctor
1.3
16.1
1470
11886
R03BB04
ATC
tiotropium bromide; inhalant
1.5
16.1
559
3817
L04AX04
ATC
lenalidomide; oral
5.5
16.1
47
86
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.5
16.1
123
491
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.2
16.0
84
265
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.6
16.0
73
207
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
16.0
316
1863
R52.2
ICD-10 Finland
Other chronic pain
2.1
16.0
185
901
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.8
16.0
286
1636
M05BX04
ATC
denosumab; parenteral
1.8
16.0
300
1741
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
16.0
321
1902
L12
ICPC
Hand/finger symptom/complaint
1.4
15.9
693
4956
L88
ICPC
Rheumatoid/seropositive arthritis
2.0
15.9
209
1071
L20.0
ICD-10 Finland
Besnier prurigo
1.8
15.9
265
1480
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
15.9
2125
18051
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
15.9
1364
10932
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
15.9
2799
24562
R01AD09
ATC
mometasone; nasal
1.3
15.8
2223
18994
UKC02
NOMESCO Finland
Cystoscopy
1.4
15.8
884
6624
R04.0
ICD-10 Finland
Epistaxis
1.6
15.7
400
2534
E000001
ATC
NA
1.4
15.7
1061
8202
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.2
15.6
156
713
G530, B029
ICD-10 Finland
NA
+∞
15.6
15
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
15.6
227
1209
M48.0
ICD-10 Finland
Spinal stenosis
1.4
15.6
684
4899
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
15.6
275
1567
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
15.6
217
1140
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
15.6
208
1073
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
15.6
377
2357
SPAT1216
SPAT
Assessment of functional ability
1.4
15.5
893
6723
Z94.2
ICD-10 Finland
Lung transplant status
13.7
15.5
26
19
5AB14
NOMESCO Finland
NA
13.7
15.5
26
19
L04AB04
ATC
adalimumab; parenteral
2.9
15.4
95
334
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.1
15.4
178
867
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
15.4
783
5768
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
15.4
982
7523
ZX121
NOMESCO Finland
Central venous catheter
6.5
15.3
39
60
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
15.3
310
1844
R02
ICPC
Shortness of breath/dyspnoea
1.5
15.3
646
4594
A07EC02
ATC
mesalazine; oral, rectal
1.8
15.3
265
1503
L03
ICPC
Low back symptom/complaint
1.3
15.2
1219
9668
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
15.1
117
470
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
15.1
633
4494
153
Kela drug reimbursment
Lenalidomid
5.0
15.1
48
97
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
15.1
2668
23369
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.8
15.0
257
1451
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
9.4
14.9
30
32
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
14.9
192
977
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.1
14.9
172
838
J01FA09
ATC
clarithromycin; systemic
1.3
14.9
1543
12677
ZXC50
NOMESCO Finland
Cryotherapy
2.0
14.9
181
901
J05AB09
ATC
famciclovir; oral
4.9
14.9
48
99
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
7.6
14.8
34
45
5BA08
NOMESCO Finland
NA
4.7
14.8
50
108
XQ848
NOMESCO Finland
Dermatological photography
2.2
14.8
148
679
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
14.8
399
2565
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
14.8
513
3502
WX892
NOMESCO Finland
Monitored bed care
1.6
14.8
396
2543
XG410
NOMESCO Finland
Flow-volume spirometry
1.9
14.8
230
1256
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
14.7
1266
10138
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.0
14.7
84
280
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
14.7
350
2178
Z94.4
ICD-10 Finland
Liver transplant status
7.4
14.6
34
46
C03DA01
ATC
spironolactone; oral
1.5
14.6
604
4273
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
14.6
679
4916
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
14.6
1341
10836
E000006
ATC
NA
1.6
14.6
375
2381
Z01.2
ICD-10 Finland
Dental examination
1.3
14.6
1980
16810
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
14.6
1365
11058
J01CF05
ATC
flucloxacillin; systemic
2.0
14.5
196
1019
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
14.4
960
7397
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
14.4
481
3252
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
14.4
223
1218
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
14.3
3641
33088
G04CA02
ATC
tamsulosin; oral
1.3
14.3
1150
9114
B00.1
ICD-10 Finland
Herpesviral vesicular dermatitis
4.5
14.3
50
112
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.0
14.3
80
266
7151
FHL
Kidney transplantation
17.0
14.3
22
13
X58
ICD-10 Finland
Exposure to other specified factors
1.4
14.3
623
4459
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
14.2
518
3573
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
14.2
304
1836
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
14.2
253
1447
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.4
14.1
67
197
R05
ICPC
Cough
1.3
14.1
1115
8820
A28
ICPC
Limited function/disability NOS
1.4
14.0
868
6604
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
14.0
239
1347
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
14.4
14.0
23
16
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
14.0
1548
12809
K50.8
ICD-10 Finland
Other Crohn disease
3.0
14.0
80
268
YNB10
NOMESCO Finland
Collection of stem cells for transplant
10.0
13.9
27
27
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
13.9
303
1842
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
2.6
13.9
100
389
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
5.5
13.8
40
73
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
13.8
793
5958
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
13.8
351
2223
S76
ICPC
Skin infection other
1.7
13.8
264
1545
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
13.8
1515
12520
B00.11
ICD-10 Finland
Herpes simplex labialis
3.5
13.7
63
181
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.1
13.7
42
82
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
13.7
437
2924
Z94.1
ICD-10 Finland
Heart transplant status
8.6
13.7
29
34
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
10.4
13.7
26
25
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
13.6
474
3238
0532X
ICD-9 Finland
Herpes zoster, With ophthalmic complications[HERPES ZOSTER CUM COMPLICATIONE OPHTALMICA ALIA]
+∞
13.5
13
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.2
13.5
134
613
S21
ICPC
Skin texture symptom/complaint
1.4
13.5
624
4512
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
13.5
2375
20713
A04AA02
ATC
granisetron; systemic, transdermal
1.6
13.5
314
1944
M13.9
ICD-10 Finland
Arthritis, unspecified
1.6
13.4
342
2172
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
25.8
13.3
18
7
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.2
13.3
139
649
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.1
13.3
149
719
N06AB04
ATC
citalopram; systemic
1.3
13.3
1092
8672
N19
ICD-10 Finland
Unspecified kidney failure
1.9
13.3
188
994
RS220
NOMESCO Finland
NA
3.0
13.3
76
255
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
13.8
13.2
22
16
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.8
13.2
83
298
L03.2
ICD-10 Finland
Cellulitis of face
4.6
13.2
45
99
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
13.2
667
4902
T78.4
ICD-10 Finland
Allergy, unspecified
1.9
13.1
205
1123
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
13.1
3391
30736
B34.9
ICD-10 Finland
Viral infection, unspecified
2.2
13.1
126
569
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
13.0
3239
29239
R4190
NOMESCO Finland
Nutritional therapy
2.1
12.9
153
755
SPAT1229
SPAT
Assessment of need for aid
1.5
12.9
454
3105
XF404
NOMESCO Finland
Ambulatory ECG
1.5
12.9
494
3443
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
6.1
12.8
34
56
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
12.8
305
1901
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
12.7
161
817
R13
ICD-10 Finland
Dysphagia
1.6
12.7
330
2102
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.6
12.7
92
360
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.2
12.7
127
584
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
3.8
12.6
52
137
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
12.6
155
777
N01
ICPC
Headache
1.5
12.6
444
3041
A07AA09
ATC
vancomycin; oral
2.7
12.5
84
314
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
7.0
12.5
30
43
196
Kela drug reimbursment
Paricalcitol and cinacalcet
6.1
12.5
33
54
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
12.5
245
1442
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
12.5
12
*
H62.1*B00.19
ICD-10 Finland
Otitis externa in herpesviral [herpes simplex] infection
+∞
12.5
12
*
H191, B023
ICD-10 Finland
NA
+∞
12.5
12
*
0531A
ICD-9 Finland
Herpes zoster, With other nervous system complications
+∞
12.5
12
*
C01DA14
ATC
isosorbide mononitrate; oral
1.3
12.5
937
7340
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
12.5
318
2014
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
8.7
12.5
26
30
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.9
12.4
173
909
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
12.4
461
3191
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
12.4
2792
24906
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.0
12.4
71
238
R52.0
ICD-10 Finland
Acute pain
2.0
12.4
149
740
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
12.4
1175
9512
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
12.3
139
672
390
Kela drug reimbursment
Ibrutinib
11.6
12.3
22
19
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
12.3
654
4851
GDG10
NOMESCO Finland
Bilateral transplantation of lung
14.3
12.2
20
14
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
12.2
241
1425
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.6
12.2
312
1981
ZY010
NOMESCO Finland
Hospital outpatient
1.8
12.2
206
1158
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
12.2
259
1564
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
12.2
528
3774
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.1
12.1
65
211
M01AE02
ATC
naproxen; oral, rectal
1.2
12.0
2961
26615
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.2
12.0
117
532
S19
ICPC
Skin injury other
1.8
11.9
196
1092
M01CB01
ATC
sodium aurothiomalate; parenteral
2.5
11.9
93
377
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
11.9
480
3381
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.7
11.9
234
1384
S06.0
ICD-10 Finland
Concussion
1.4
11.8
499
3546
A01AB09
ATC
miconazole; local oral
1.5
11.8
475
3340
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
11.8
514
3673
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
11.8
1012
8072
M10.9
ICD-10 Finland
Gout, unspecified
1.6
11.8
322
2078
B01AB10
ATC
tinzaparin; parenteral
1.6
11.8
348
2287
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
11.8
219
1270
5AB01
NOMESCO Finland
NA
11.7
11.8
21
18
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.7
11.8
233
1379
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
11.8
260
1587
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.2
11.7
35
67
329
Kela drug reimbursment
Lenalidomide
5.6
11.7
33
59
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.0
11.7
142
710
R03BA08
ATC
ciclesonide; inhalant
1.5
11.7
381
2563
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
11.7
1050
8430
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.4
11.7
56
168
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.4
11.7
96
403
XQ800
NOMESCO Finland
Prick test
1.6
11.7
325
2110
R06AX27
ATC
desloratadine; oral
1.3
11.6
1206
9862
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
11.6
214
1239
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
7.7
11.6
26
34
XCH00
NOMESCO Finland
Eye pressure measurement
1.8
11.5
213
1233
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
11.5
430
2979
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
11.5
2006
17399
J20
ICD-10 Finland
Acute bronchitis
1.5
11.5
451
3156
N06AX11
ATC
mirtazapine; oral
1.2
11.5
1619
13728
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
11.5
1162
9470
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.7
11.5
76
281
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
11.5
326
2123
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.2
11.5
58
181
H19.0*B02.3
ICD-10 Finland
Zoster scleritis
+∞
11.5
11
*
05307
ICD-8 Finland
Herpes zoster, Suspectus
+∞
11.5
11
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.6
11.5
335
2200
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
11.5
225
1330
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.0
11.4
66
225
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
11.4
118
550
V03AE03
ATC
lanthanum carbonate; oral
7.5
11.4
26
35
A41.8
ICD-10 Finland
Other specified sepsis
2.3
11.4
100
434
A10AE05
ATC
insulin detemir; parenteral
1.6
11.4
263
1626
DFF00
NOMESCO Finland
Pure tone audiometry
1.5
11.4
441
3083
XCK00
NOMESCO Finland
Perimetry
1.5
11.4
352
2342
WZA90
NOMESCO Finland
Other doctors statement
1.3
11.3
1089
8820
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
11.3
1209
9925
1512
Kela drug reimbursment
Ibrutinib
11.8
11.3
20
17
H13.1
ICD-10 Finland
Conjunctivitis in infectious and parasitic diseases classified elsewhere
15.0
11.3
18
12
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
11.3
351
2337
K51.5
ICD-10 Finland
Left sided colitis
2.1
11.2
118
557
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
8.9
11.2
23
26
TPX15
NOMESCO Finland
Removal of vascular injection port
4.5
11.2
38
84
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
11.2
722
5523
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
11.2
165
888
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
11.2
330
2171
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
11.1
237
1433
2AX04
NOMESCO Finland
NA
20.0
11.1
16
8
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
11.1
300
1933
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.4
11.1
454
3209
A04
ICPC
Weakness/tiredness general
1.4
11.1
679
5154
Z51.5
ICD-10 Finland
Palliative care
1.6
11.1
320
2098
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
11.1
466
3308
C83.00
ICD-10 Finland
Lymphocytic lymphoma
6.4
11.0
28
44
R31
ICD-10 Finland
Unspecified haematuria
1.4
11.0
507
3661
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.4
11.0
88
364
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.0
11.0
128
632
1CX01
NOMESCO Finland
NA
10.0
11.0
21
21
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
11.0
498
3588
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
13.9
10.9
18
13
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
10.9
268
1685
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
10.9
149
782
K07.60
ICD-10 Finland
Snapping jaw
1.7
10.9
202
1172
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
10.9
216
1279
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.4
10.9
475
3395
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
10.9
475
3397
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
10.9
787
6128
I50.0
ICD-10 Finland
Congestive heart failure
1.5
10.8
418
2919
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
10.8
586
4362
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.3
10.7
98
433
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
10.7
293
1892
WX402
NOMESCO Finland
General anaesthesia
1.3
10.7
742
5735
B00.0
ICD-10 Finland
Eczema herpeticum
5.0
10.7
33
66
N03AE01
ATC
clonazepam; systemic
1.6
10.7
287
1847
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
10.7
103
465
187
Kela drug reimbursment
MPA
28.0
10.7
14
5
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
17.8
10.7
16
9
RS221
NOMESCO Finland
NA
2.5
10.7
83
339
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
10.7
837
6592
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
10.7
272
1727
N06AX16
ATC
venlafaxine; oral
1.4
10.7
586
4369
B01AC04
ATC
clopidogrel; oral
1.3
10.7
839
6611
C82.1
ICD-10 Finland
Follicular lymphoma grade II
3.6
10.6
47
133
W19
ICD-10 Finland
Unspecified fall
1.4
10.6
470
3373
AN1
HP
Coronary angiography
1.4
10.6
633
4782
H02.4
ICD-10 Finland
Ptosis of eyelid
1.9
10.6
142
740
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
10.6
1234
10227
207
Kela drug reimbursment
Chronic arrhythmias
1.3
10.5
800
6272
H25.8
ICD-10 Finland
Other senile cataract
1.4
10.5
624
4707
R4180
NOMESCO Finland
Podiatric therapy
3.0
10.5
57
188
S71
ICPC
Herpes simplex
3.8
10.5
43
114
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.3
10.5
96
423
M32
ICD-10 Finland
Systemic lupus erythematosus
14.2
10.5
17
12
D11AX14
ATC
[U] tacrolimus; topical
5.2
10.4
31
60
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
10.4
403
2819
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.9
10.4
138
716
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
10.4
374
2577
JJC00
NOMESCO Finland
Allogenic transplantation of liver
7.7
10.4
23
30
L50.9
ICD-10 Finland
Urticaria, unspecified
1.8
10.3
158
864
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.6
10.3
74
290
A29
ICPC
General symptom/complaint other
1.4
10.3
562
4183
ZX114
NOMESCO Finland
Intramuscular
2.4
10.3
81
334
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
10.3
605
4561
GD2SN
NOMESCO Finland
Lung ventilation SPECT
3.4
10.3
47
137
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.9
10.3
157
856
H26.4
ICD-10 Finland
After-cataract
1.4
10.3
523
3850
N03AX09
ATC
lamotrigine; oral
1.8
10.2
178
1014
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
18.8
10.2
15
8
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.8
10.2
64
229
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
10.2
272
1745
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.0
10.2
59
201
R51.81
ICD-10 Finland
Facial pain NOS
2.2
10.2
103
478
J01EA01
ATC
trimethoprim; systemic
1.2
10.2
1387
11691
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
10.2
427
3031
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
10.2
685
5275
C07AB02
ATC
metoprolol; systemic
1.3
10.1
1183
9802
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.0
10.1
123
616
J01CA08
ATC
pivmecillinam; oral
1.2
10.1
2125
18718
R33
ICD-10 Finland
Retention of urine
1.5
10.1
394
2758
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
10.1
352
2406
B01AB04
ATC
dalteparin; parenteral
1.6
10.1
250
1577
M05BA07
ATC
risedronic acid; oral
1.7
10.1
198
1170
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
10.1
198
1170
212
Kela drug reimbursment
Gout
2.1
10.1
114
557
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
10.1
417
2954
R03BA05
ATC
fluticasone; inhalant
1.3
10.0
883
7062
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
10.0
698
5400
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.2
10.0
101
468
C09CA01
ATC
losartan; oral
1.2
10.0
1245
10387
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
10.0
61
218
J01XX08
ATC
linezolid; systemic
4.1
10.0
37
90
D09AB01
ATC
zinc bandage without supplements; topical
2.1
10.0
108
516
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.9
10.0
141
749
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.7
10.0
195
1152
D07AD01
ATC
clobetasol; topical
1.3
9.9
740
5784
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
5.5
9.9
28
51
M01AC06
ATC
meloxicam; systemic, rectal
1.2
9.9
1884
16430
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
16.7
9.9
15
9
SBB10
NOMESCO Finland
Teeth copy
1.6
9.9
254
1621
C83.1
ICD-10 Finland
Mantle cell lymphoma
4.3
9.8
35
82
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.7
9.8
66
247
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
9.8
621
4732
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
12.2
9.8
17
14
L04AA05
ATC
[U] tacrolimus; systemic
12.2
9.8
17
14
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.2
9.8
17
14
F29
ICPC
Eye symptom/complaint other
1.5
9.8
387
2716
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
5.2
9.8
29
56
N03
ICPC
Pain face
3.2
9.8
50
159
H01AC01
ATC
somatropin; parenteral
8.7
9.8
20
23
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
9.8
317
2136
K59.0
ICD-10 Finland
Constipation
1.5
9.7
290
1916
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
9.5
9.7
19
20
TK820
NOMESCO Finland
Peritoneal dialysis
4.8
9.7
31
65
S06
ICPC
Rash localized
1.6
9.7
271
1762
WVA20
NOMESCO Finland
Medicine administration
2.1
9.7
101
474
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
9.7
283
1862
H05BX01
ATC
cinacalcet; oral
4.0
9.7
37
93
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
9.7
292
1935
M54.2
ICD-10 Finland
Cervicalgia
1.5
9.7
313
2109
SPAT1234
SPAT
Support of social functional capacity
1.5
9.6
278
1823
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
5.8
9.6
26
45
E000002
ATC
NA
1.4
9.6
519
3858
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
9.6
1116
9238
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
9.6
621
4753
CG2S4
NOMESCO Finland
Photography of cornea
4.4
9.6
33
75
321
Kela drug reimbursment
Paricalcitol and cinacalcet
4.1
9.6
36
89
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.9
9.6
134
711
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.5
9.6
43
124
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
9.6
179
1043
A10AE04
ATC
insulin glargine; parenteral
1.4
9.6
442
3196
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.1
9.5
108
529
N02AC04
ATC
dextropropoxyphene; oral
1.7
9.5
208
1269
J46
ICD-10 Finland
Status asthmaticus
1.9
9.5
139
747
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
9.5
464
3388
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
9.5
177
1034
-1
NOMESCO Finland
NA
1.2
9.5
1541
13221
D02AE01
ATC
carbamide; topical
1.5
9.5
315
2134
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.6
9.5
216
1337
H92.0
ICD-10 Finland
Otalgia
1.6
9.5
227
1421
G530, B022
ICD-10 Finland
NA
100.2
9.4
10
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
30.0
9.4
12
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
30.0
9.4
12
*
C08CA13
ATC
lercanidipine; oral
1.3
9.4
673
5227
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.7
9.4
179
1050
0530A
ICD-9 Finland
Herpes zoster, With meningitis
+∞
9.4
9
*
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
9.4
9
*
UDC00
NOMESCO Finland
Ear microscopy
1.5
9.4
337
2321
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.7
9.4
177
1036
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.5
9.3
72
295
N05BB01
ATC
hydroxyzine; systemic
1.5
9.3
309
2090
L01XE27
ATC
[U] ibrutinib; oral
12.3
9.3
16
13
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
12.3
9.3
16
13
ZX131
NOMESCO Finland
Intrathecal
21.7
9.3
13
6
L05
ICPC
Flank/axilla symptom/complaint
1.6
9.3
257
1667
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
9.3
3619
33557
L50.0
ICD-10 Finland
Allergic urticaria
1.9
9.3
123
639
H13
ICPC
Plugged feeling ear
1.3
9.2
905
7331
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
9.2
930
7560
H53.2
ICD-10 Finland
Diplopia
1.8
9.2
145
802
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
9.2
217
1354
A86
ICD-10 Finland
Unspecified viral encephalitis
4.1
9.2
34
83
R03BA01
ATC
beclometasone; inhalant
1.3
9.2
696
5449
GD1UN
NOMESCO Finland
Lung circulation SPECT
3.5
9.2
41
118
R01AD08
ATC
fluticasone; nasal
1.2
9.2
1316
11142
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
4.3
9.2
32
74
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
2.7
9.2
62
234
C08CA05
ATC
nifedipine; systemic
1.5
9.2
346
2408
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
9.1
1020
8396
R03AC12
ATC
salmeterol; inhalant
1.6
9.1
243
1564
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
9.1
124
651
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
3.2
9.1
45
140
R5120
NOMESCO Finland
Preparation of an aid
1.9
9.1
136
739
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
9.1
349
2436
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
9.1
1121
9336
C01CA24
ATC
epinephrine; parenteral
1.6
9.1
242
1558
R01AD12
ATC
fluticasone furoate; nasal
1.2
9.0
1275
10773
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
5.9
9.0
24
41
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
9.0
510
3821
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
15.6
9.0
14
9
B00.8
ICD-10 Finland
Other forms of herpesviral infection
10.0
9.0
17
17
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.4
9.0
372
2633
Z50.1
ICD-10 Finland
Other physical therapy
1.5
9.0
269
1782
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
2.8
8.9
55
199
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.7
8.9
59
223
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
8.9
245
1589
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
8.9
539
4082
A87.9
ICD-10 Finland
Viral meningitis, unspecified
3.9
8.9
35
91
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.8
8.9
136
746
F01
ICPC
Eye pain
1.9
8.9
122
645
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.9
8.9
132
718
L01EL01
ATC
ibrutinib; oral
12.5
8.8
15
12
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.7
8.8
162
942
XKD00
NOMESCO Finland
Uroflowmetry
1.3
8.8
766
6111
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.2
8.8
32
77
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.2
8.8
86
396
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
7.9
8.8
19
24
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
7.9
8.8
19
24
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
8.8
516
3885
KH1AD
NOMESCO Finland
CT of urinary organs
1.8
8.8
141
782
D11AH01
ATC
tacrolimus; topical
3.4
8.8
40
117
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.6
8.8
60
228
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
8.8
379
2706
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
8.8
304
2079
M54.6
ICD-10 Finland
Pain in thoracic spine
1.5
8.8
283
1902
Z99.2
ICD-10 Finland
Dependence on renal dialysis
10.7
8.8
16
15
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
8.8
409
2966
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.9
8.8
51
177
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.4
8.7
40
118
A03
ICPC
Fever
1.3
8.7
649
5067
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.9
8.7
116
604
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
3.9
8.7
34
88
WF049
NOMESCO Finland
Radiotherapy of metastasis
1.7
8.7
155
895
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.8
8.6
153
882
K30
ICD-10 Finland
Functional dyspepsia
1.4
8.6
475
3544
EBA00
NOMESCO Finland
Extraction of tooth
1.2
8.6
1540
13323
G35
ICD-10 Finland
Multiple sclerosis
2.4
8.6
69
287
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
4.3
8.6
30
70
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
2.5
8.6
64
259
JN4CD
NOMESCO Finland
Very extensive body CT
1.6
8.6
200
1244
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.8
8.6
150
858
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.9
8.6
115
600
R4120
NOMESCO Finland
Occupational therapy
1.5
8.6
285
1932
XQ802
NOMESCO Finland
Epicutan test
1.7
8.6
168
997
A10BH01
ATC
sitagliptin; oral
1.4
8.6
453
3358
HA1AA
NOMESCO Finland
X-ray mammography
1.4
8.5
355
2519
T90
ICPC
Diabetes non-insulin dependent
1.2
8.5
1136
9534
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.5
8.5
247
1624
D01
ICPC
Abdominal pain/cramps general
1.4
8.5
468
3490
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.2
8.5
80
361
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
2.5
8.5
65
264
G50.1
ICD-10 Finland
Atypical facial pain
2.2
8.5
83
383
M01AB05
ATC
diclofenac; systemic, rectal
1.2
8.5
3501
32501
A12BA01
ATC
potassium chloride; oral
1.5
8.4
270
1814
K08.80
ICD-10 Finland
Toothache NOS
1.5
8.4
308
2132
H62.1
ICD-10 Finland
Otitis externa in viral diseases classified elsewhere
90.2
8.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
3.0
8.4
46
155
C09AA05
ATC
ramipril; oral
1.2
8.4
1326
11327
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
3.7
8.4
34
91
C02AC05
ATC
moxonidine; oral
1.6
8.4
222
1426
C10AA01
ATC
simvastatin; oral
1.2
8.4
2467
22284
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.4
8.4
333
2344
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
8.4
80
366
B01AF02
ATC
apixaban; oral
1.4
8.4
497
3753
L01AA02
ATC
chlorambucil; oral
4.2
8.4
30
72
0532B
ICD-9 Finland
Herpes zoster, With ophthalmic complications[HERPES ZOSTER KERATOCONJUNCTIVITIS]
+∞
8.3
8
*
UJF92
NOMESCO Finland
Capsular endoscopy
2.1
8.3
91
439
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.0
8.3
94
464
I50.1
ICD-10 Finland
Left ventricular failure
1.5
8.2
238
1565
E000003
ATC
NA
1.6
8.2
203
1281
K51.8
ICD-10 Finland
Other ulcerative colitis
2.4
8.2
64
264
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
8.2
360
2578
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.4
8.2
349
2487
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
8.2
375
2706
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.5
8.2
266
1795
H03AA01
ATC
levothyroxine sodium; systemic
1.2
8.2
1190
10078
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.6
8.2
217
1399
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.7
8.2
178
1090
R74
ICPC
Upper respiratory infection acute
1.2
8.2
1177
9959
M01AX17
ATC
nimesulide; oral
1.2
8.2
1289
11006
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.0
8.1
97
486
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
7.5
8.1
18
24
S22.3
ICD-10 Finland
Fracture of rib
1.5
8.1
291
2004
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
8.1
463
3473
R03DC03
ATC
montelukast; oral
1.3
8.1
723
5787
M35.1
ICD-10 Finland
Other overlap syndromes
3.6
8.1
34
94
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
8.1
368
2653
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
8.1
398
2914
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.5
8.1
239
1579
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
8.1
643
5070
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
17.2
8.1
12
7
E86
ICD-10 Finland
Volume depletion
1.8
8.1
127
704
ZX197
NOMESCO Finland
NA
11.7
8.1
14
12
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.8
8.1
142
817
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
4.4
8.0
27
61
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.4
8.0
334
2372
M43.4
ICD-10 Finland
Other recurrent atlantoaxial subluxation
8.9
8.0
16
18
J45.8
ICD-10 Finland
Mixed asthma
1.7
8.0
147
856
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.2
8.0
79
364
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.6
8.0
178
1096
A10BH05
ATC
linagliptin; oral
1.5
8.0
242
1609
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.4
7.9
63
264
SPAT1167
SPAT
Insertion of urinary catheter
1.7
7.9
169
1029
L29
ICPC
Musculoskeletal sympt/complt other
1.4
7.9
352
2529
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.3
7.9
68
295
ZXE40
NOMESCO Finland
More than seven and less than nine hours
1.9
7.9
116
627
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.9
7.9
116
628
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
7.9
1520
13223
L13
ICPC
Hip symptom/complaint
1.3
7.9
778
6304
R21
ICPC
Throat symptom/complaint
1.3
7.9
809
6588
J02AC04
ATC
posaconazole; systemic
13.0
7.9
13
10
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.4
7.9
62
259
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.0
7.8
101
521
D11AH02
ATC
pimecrolimus; topical
5.1
7.8
23
45
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
7.8
168
1026
R04.2
ICD-10 Finland
Haemoptysis
1.7
7.8
171
1047
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.8
7.8
134
763
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
7.8
862
7083
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.4
7.8
457
3442
K03.66
ICD-10 Finland
Tooth plaque
1.5
7.8
287
1987
B72
ICPC
Hodgkin Lymphoma
8.4
7.8
16
19
I20.09
ICD-10 Finland
Unstable angina
1.5
7.8
290
2016
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
7.8
255
1725
ZZA00
NOMESCO Finland
Split skin graft
1.7
7.8
143
833
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.8
138
798
C10AA03
ATC
pravastatin; oral
1.4
7.7
366
2661
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.5
7.7
34
98
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.1
7.7
82
392
7101
FHL
Needle biopsy in the operating room
45.0
7.7
9
*
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.0
7.7
96
491
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
1.9
7.7
102
532
A07EA02
ATC
hydrocortisone; rectal
1.9
7.7
104
547
RD210
NOMESCO Finland
NA
2.1
7.7
80
381
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.5
7.7
219
1435
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.7
7.7
49
180
M31.3
ICD-10 Finland
Wegener granulomatosis
4.2
7.7
27
64
M54.3
ICD-10 Finland
Sciatica
1.5
7.7
261
1780
SPAT1097
SPAT
Recording of ECG
1.3
7.7
770
6252
S01BC05
ATC
ketorolac; ophthalmic
1.6
7.7
213
1390
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.2
7.6
37
115
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.6
7.6
189
1199
L08
ICPC
Shoulder symptom/complaint
1.2
7.6
877
7239
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
3.3
7.6
35
105
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
7.6
736
5955
2041A
ICD-9 Finland
Lymphoid leukaemia, Chronic
25.0
7.6
10
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.5
7.6
236
1581
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
7.6
5028
48236
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.9
7.5
44
154
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
7.5
320
2283
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
1.9
7.5
99
519
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
1.7
7.5
135
783
R83
ICPC
Respiratory infection other
1.2
7.5
908
7536
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
3.4
7.5
34
101
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.5
7.5
53
210
K07
ICPC
Swollen ankles/oedema
1.5
7.5
224
1486
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
7.4
233
1563
R03BA02
ATC
budesonide; inhalant
1.2
7.4
833
6855
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.3
7.4
446
3375
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
3.6
7.4
31
86
5BA03
NOMESCO Finland
NA
80.2
7.4
8
*
M05BA01
ATC
etidronic acid; systemic
2.9
7.4
43
150
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
1.8
7.4
118
660
L14
ICPC
Leg/thigh symptom/complaint
1.4
7.4
338
2444
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.3
7.4
488
3745
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.4
2065
18528
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
7.4
498
3837
M01AH02
ATC
rofecoxib; oral
1.3
7.4
680
5464
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
13.4
7.4
12
9
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
7.6
7.4
16
21
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.1
7.4
38
124
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
7.4
87
437
SPAT1053
SPAT
Memory test
1.2
7.3
830
6833
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.5
7.3
251
1714
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.2
7.3
72
333
SPAT1131
SPAT
Colonoscopy
1.6
7.3
161
988
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.6
7.3
201
1305
C09CA06
ATC
candesartan; oral
1.2
7.3
1034
8724
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
2.1
7.3
77
368
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.4
7.3
59
251
305
Kela drug reimbursment
MPA
+∞
7.3
7
*
G02.0*B01.0
ICD-10 Finland
Varicella meningitis
+∞
7.3
7
*
BE00A
NOMESCO Finland
NA
+∞
7.3
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
7.3
7
*
G530, B0229
ICD-10 Finland
NA
+∞
7.3
7
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
7.3
7
*
ZX100
NOMESCO Finland
Oral
2.2
7.3
70
323
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
1.9
7.3
95
497
L95
ICPC
Osteoporosis
1.6
7.2
160
984
H15.1
ICD-10 Finland
Episcleritis
2.3
7.2
61
265
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
7.2
1859
16563
Z2445
NOMESCO Finland
Psychologist
1.7
7.2
150
910
J96.1
ICD-10 Finland
Chronic respiratory failure
1.8
7.2
108
591
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.1
7.2
76
364
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
1.9
7.2
106
577
D06BB04
ATC
podophyllotoxin; topical
1.6
7.2
168
1052
L30.0
ICD-10 Finland
Nummular dermatitis
1.7
7.2
151
917
N76.0
ICD-10 Finland
Acute vaginitis
1.6
7.1
182
1164
H26.2
ICD-10 Finland
Complicated cataract
2.3
7.1
63
279
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
20.0
7.1
10
5
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
4.8
7.1
22
46
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
7.1
988
8318
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.6
7.1
177
1126
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
7.1
115
646
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
7.1
474
3645
B73
ICPC
Leukaemia
6.6
7.1
17
26
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
7.1
271
1895
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.8
7.1
111
616
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
7.1
89
458
A76
ICPC
Viral exanthem other
2.9
7.1
41
143
R35
ICD-10 Finland
Polyuria
1.4
7.1
282
1986
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
2.4
7.1
54
223
M05BA06
ATC
ibandronic acid; systemic
1.9
7.1
103
557
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.0
7.1
85
431
HMAK
NOMESCO Finland
NA
1.3
7.1
504
3913
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
7.1
490
3791
A03FA02
ATC
cisapride; oral, rectal
1.4
7.1
401
3008
E66.01
ICD-10 Finland
Obesity due to excess calories
1.4
7.0
290
2056
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.6
7.0
29
80
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.6
7.0
29
80
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.8
7.0
118
670
M01AH05
ATC
etoricoxib; oral
1.2
7.0
2911
26873
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
2.4
7.0
56
235
K92.1
ICD-10 Finland
Melaena
1.5
7.0
260
1807
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.5
7.0
210
1397
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
7.0
7.0
16
23
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.1
7.0
75
364
D01AC02
ATC
miconazole; topical
1.4
7.0
380
2835
J01DA06
ATC
[U] cefuroxime; systemic
1.3
7.0
672
5431
J47
ICD-10 Finland
Bronchiectasis
1.9
7.0
96
509
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
6.9
206
1363
L04AA17
ATC
[U] adalimumab; parenteral
3.8
6.9
27
71
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
1.7
6.9
121
697
I20.00
ICD-10 Finland
Unstable angina
1.6
6.9
162
1014
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
6.3
6.9
17
27
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.5
6.9
206
1368
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
1.8
6.9
102
557
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
7.5
6.9
15
20
S01AX11
ATC
[U] ofloxacin; ophthalmic
1.6
6.9
181
1168
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
6.9
847
7039
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
13.8
6.9
11
8
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.2
6.9
66
302
M79.7
ICD-10 Finland
Fibromyalgia
1.7
6.9
136
812
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.1
6.8
74
360
WX872
NOMESCO Finland
Intensive care
1.5
6.8
226
1536
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
3.8
6.8
27
72
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
6.8
979
8269
R06.2
ICD-10 Finland
Wheezing
1.5
6.8
191
1249
SPAT1240
SPAT
Therapeutic discussion
1.3
6.8
404
3054
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.8
203
1347
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
2.9
6.8
37
126
WW402
NOMESCO Finland
Leucoferesis
6.7
6.8
16
24
5602
FHL
Internal fistula (eg Cimino)
10.9
6.8
12
11
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
10.9
6.8
12
11
C10AC01
ATC
colestyramine; oral
1.7
6.8
118
681
Z00.8
ICD-10 Finland
Other general examinations
1.4
6.8
318
2312
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.6
6.8
152
940
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.1
6.8
75
366
E87.6
ICD-10 Finland
Hypokalaemia
1.6
6.8
144
881
XX4BW
NOMESCO Finland
NA
6.1
6.8
17
28
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
6.8
235
1613
L04AB01
ATC
etanercept; parenteral
2.2
6.7
61
275
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
3.8
6.7
26
68
S01ED51
ATC
timolol, combinations; ophthalmic
1.4
6.7
379
2840
L04AB06
ATC
golimumab; parenteral
2.9
6.7
37
127
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.7
6.7
140
848
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.7
236
1621
R51
ICD-10 Finland
Headache
1.5
6.7
199
1321
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
6.7
461
3560
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.8
6.7
104
577
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
4.7
6.7
21
45
A02BC04
ATC
rabeprazole; oral
1.4
6.7
361
2690
KAS40
NOMESCO Finland
Excision of transplanted kidney
22.5
6.7
9
*
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.4
6.7
51
211
ZX140
NOMESCO Finland
Intra articular
2.7
6.7
43
160
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.5
6.6
186
1218
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
3.8
6.6
26
69
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.2
6.6
65
303
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.3
6.6
31
95
K12.10
ICD-10 Finland
Stomatitis NOS
3.1
6.6
33
106
WW400
NOMESCO Finland
Plasmaferesis
6.4
6.6
16
25
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
1.8
6.6
96
523
R06.4
ICD-10 Finland
Hyperventilation
2.1
6.6
70
338
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
2.2
6.6
62
283
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
5.1
6.6
19
37
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
2.7
6.6
43
162
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
6.6
157
987
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
5.9
6.6
17
29
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
5.5
6.6
18
33
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.3
6.6
513
4035
A99
ICPC
Disease/condition unspecnature/site
1.4
6.6
366
2737
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
6.6
157
990
I95.9
ICD-10 Finland
Hypotension, unspecified
2.1
6.6
72
353
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.6
6.5
27
75
L04AA11
ATC
[U] etanercept; parenteral
3.6
6.5
27
75
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.1
6.5
71
344
J04AB02
ATC
rifampicin; systemic
2.2
6.5
62
286
WX610
NOMESCO Finland
Patient controlled analgesia
3.3
6.5
30
91
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
1.5
6.5
180
1176
I50
ICD-10 Finland
Heart failure
1.6
6.5
161
1023
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
4.8
6.5
20
42
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
4.3
6.5
22
51
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.5
6.5
186
1224
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.5
6.5
180
1177
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
3.1
6.5
32
102
1XX32
NOMESCO Finland
NA
6.8
6.5
15
22
K06.10
ICD-10 Finland
Gingival fibromatosis
6.8
6.5
15
22
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
6.8
6.5
15
22
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
6.5
660
5369
S20.2
ICD-10 Finland
Contusion of thorax
1.5
6.5
201
1349
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.5
6.5
47
190
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.7
6.5
124
736
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.7
6.5
131
791
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.5
1882
16899
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
6.5
157
992
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
2.0
6.5
73
361
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.6
6.5
27
76
L01AA03
ATC
melphalan; systemic
4.5
6.4
21
47
A02BA04
ATC
nizatidine; systemic
1.3
6.4
390
2957
6119
FHL
Other measure in this category
69.9
6.4
7
*
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.4
6.4
298
2161
L03AA14
ATC
lipegfilgrastim; parenteral
1.9
6.4
80
413
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.7
6.4
120
708
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
4.2
6.4
22
52
H81
ICPC
Excessive ear wax
1.2
6.4
793
6594
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.6
6.4
43
167
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
2.6
6.4
43
167
R50.8
ICD-10 Finland
Other specified fever
3.2
6.4
31
98
ZXE80
NOMESCO Finland
More than 18 and less than 21 hours
4.7
6.4
20
43
L03AX13
ATC
glatiramer acetate; parenteral
3.9
6.4
24
62
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.5
6.3
187
1238
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.3
6.3
378
2859
JN6AD
NOMESCO Finland
CT of torso and neck
2.2
6.3
60
276
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.5
6.3
212
1447
L53.9
ICD-10 Finland
Erythematous condition, unspecified
2.3
6.3
54
235
TAC00
NOMESCO Finland
Peripheral nerve block
3.4
6.3
28
83
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
6.3
168
1088
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.4
6.3
338
2518
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
4.2
6.3
22
53
SPAT1252
SPAT
Overall medication plan or its review
1.4
6.3
347
2597
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
9.2
6.3
12
13
B59
ICD-10 Finland
Pneumocystosis
9.2
6.3
12
13
H17.8
ICD-10 Finland
Other corneal scars and opacities
4.6
6.3
20
44
C08DA01
ATC
verapamil; systemic
1.5
6.3
207
1408
05301
ICD-8 Finland
Herpes zoster, Oticus
+∞
6.2
6
*
0537A
ICD-9 Finland
Herpes zoster, With other specified complications[ZOSTER OTICUS]
+∞
6.2
6
*
05699
ICD-8 Finland
Rubella, Non definita
+∞
6.2
6
*
05405
ICD-8 Finland
Herpes simplex, Kerato-conjunctivitis herpetica
+∞
6.2
6
*
0538A
ICD-9 Finland
Herpes zoster, With unspecified complication[HERPES ZOSTER GENERALISATUS]
+∞
6.2
6
*
B01.8
ICD-10 Finland
Varicella with other complications
+∞
6.2
6
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
6.2
834
6991
R01AD01
ATC
beclometasone; nasal
1.2
6.2
679
5567
S01EA03
ATC
apraclonidine; ophthalmic
2.3
6.2
54
238
R06AX13
ATC
loratadine; oral
1.3
6.2
643
5241
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.7
6.2
39
146
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
26.7
6.2
8
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.0
6.2
73
366
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
4.1
6.2
22
54
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
6.2
361
2723
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
2.6
6.2
41
158
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
2.6
6.2
41
158
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.5
6.2
45
183
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
6.2
1359
11934
RS222
NOMESCO Finland
NA
2.1
6.2
64
307
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.9
6.2
86
463
D02AX
ATC
Other emollients and protectives
1.6
6.1
136
841
XF402
NOMESCO Finland
ECG with work load test
1.3
6.1
526
4191
ZZR00
NOMESCO Finland
Flap of skin
1.7
6.1
114
673
D07XC01
ATC
betamethasone, combinations; topical
1.3
6.1
533
4252
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.4
6.1
47
194
C10AX09
ATC
ezetimibe; oral
1.3
6.1
481
3786
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.4
6.1
50
213
L15
ICPC
Knee symptom/complaint
1.2
6.1
979
8357
L60.0
ICD-10 Finland
Ingrowing nail
1.5
6.1
180
1195
M87.3
ICD-10 Finland
Other secondary osteonecrosis
7.7
6.1
13
17
AP4
HP
Myocardial biopsy
7.7
6.1
13
17
K29
ICPC
Cardiovascular sympt/complt other
1.5
6.1
198
1343
C08CA02
ATC
felodipine; oral
1.3
6.1
472
3708
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
6.1
38
142
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.4
6.1
248
1761
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
2.7
6.1
37
136
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
4.6
6.1
19
41
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.7
6.1
125
757
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.6
6.1
142
893
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
6.1
578
4667
134
Kela drug reimbursment
General erythroderma
3.8
6.1
23
60
Z94.7
ICD-10 Finland
Corneal transplant status
3.8
6.1
23
60
318
Kela drug reimbursment
Teriparatide
3.0
6.1
32
108

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
270
204
13.70
287.45
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2966
17331
2.19
218.02
5.7
4.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
4332
29470
2.13
212.16
9.7
5.6
e9/l
0.0
0.0
0.33
3862
25107
(3001604) Monocytes [#/volume] in Blood
4309
29309
2.13
210.40
9.7
5.6
e9/l
0.6
0.6
0.69
3843
24963
(3013115) Eosinophils [#/volume] in Blood
4419
30451
2.12
207.06
10.2
5.8
e9/l
0.2
0.2
0.63
3986
26351
(3019198) Lymphocytes [#/volume] in Blood
4370
30134
2.10
202.45
9.8
5.6
e9/l
2.0
1.9
1.20
3951
26152
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
469
1038
4.76
196.77
8.2
4.6
iu/ml
431.2
3217.4
0.81
94
135
(3006504) Eosinophils/100 leukocytes in Blood
4064
27591
2.05
192.53
10.2
5.8
%
2.8
2.8
0.39
3829
25468
(3022096) Basophils/100 leukocytes in Blood
3973
26784
2.04
191.59
10.2
5.9
%
0.7
0.7
0.15
3737
24760
(3019069) Monocytes/100 leukocytes in Blood
4077
27758
2.04
191.06
10.7
6.1
%
8.9
8.7
3.94
3846
25741
(42870588) Differential panel, method unspecified - Blood
3238
20292
2.06
191.05
9.7
5.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
4761
34327
2.09
189.98
14.7
8.7
e9/l
4.2
4.2
0.18
4307
29719
(3002030) Lymphocytes/100 leukocytes in Blood
4134
28408
2.03
187.32
10.4
5.9
%
27.0
27.2
0.49
3882
26177
(3018010) Neutrophils/100 leukocytes in Blood
4072
27991
2.01
182.44
9.8
5.7
%
57.7
57.8
0.23
3824
25916
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
293
466
6.51
176.09
1.2
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4401
31813
1.95
162.08
9.2
5.9
umol/l
10.9
11.7
3.91
4201
30062
(3011412) CD3 cells [#/volume] in Blood
285
501
5.88
154.71
2.8
2.3
e9/l
1.1
1.1
0.58
178
297
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1443
7145
2.27
151.29
6.6
4.0
u/l
247.5
246.5
0.08
1370
6702
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4333
31634
1.89
149.34
10.4
6.5
mmol/l
1.2
1.2
0.08
3655
26474
(21494815) CD4 cells/100 lymphocytes in Specimen
257
424
6.24
148.83
2.6
2.2
%
35.5
40.0
0.62
33
54
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1886
10436
2.08
148.66
2.4
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
359
809
4.61
146.80
3.7
2.4
u/ml
3146.9
2050.0
0.19
22
59
(3010375) cycloSPORINE [Mass/volume] in Blood
170
182
9.54
143.23
36.3
22.1
ug/l
107.4
115.3
0.73
154
144
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3974
28645
1.84
138.09
9.2
5.8
mmol/l
1.2
1.2
0.19
3621
25712
(3005719) IgG [Mass/volume] in Serum or Plasma
970
4212
2.50
135.99
4.2
2.6
g/l
9.6
10.6
7.73
908
3822
(3013826) Glucose [Moles/volume] in Serum or Plasma
4723
36118
1.85
133.11
7.1
4.6
mmol/l
6.8
6.8
0.10
4522
33761
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
230
384
6.15
131.54
2.4
2.0
%
13.6
14.1
0.16
110
161
(3001964) Herpes simplex virus Ag [Presence] in Specimen
136
122
11.34
129.73
1.6
1.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
231
395
6.00
128.93
2.5
2.0
%
74.1
72.3
0.77
221
376
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
217
349
6.38
128.81
3.1
2.4
e6/l
717.0
667.7
0.27
76
153
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
222
366
6.22
128.58
2.5
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5713
46694
1.98
128.07
12.5
7.3
u/l
79.2
79.5
0.18
5458
43687
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1479
8032
2.05
119.32
9.1
5.4
mmol/l
1.1
1.0
2.43
1385
7370
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
204
343
6.09
115.80
2.9
2.5
e6/l
570.3
499.8
0.77
166
286
(3024561) Albumin [Mass/volume] in Serum or Plasma
3710
27106
1.74
114.57
7.3
4.6
g/l
34.7
35.1
3.20
3431
24971
(3013707) Erythrocyte sedimentation rate by Westergren method
5428
44313
1.84
112.84
6.4
4.1
mm/h
15.0
13.3
12.20
5048
40635
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1599
9122
1.96
111.29
3.2
2.4
g/l
2.3
2.3
1.97
1489
8356
(3027945) Reticulocytes/100 erythrocytes in Blood
1359
7325
2.05
111.11
3.8
2.5
%
1.9
1.8
2.66
1206
6397
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
195
327
6.10
110.98
3.0
2.5
e9/l
0.2
0.2
0.41
164
284
(3022948) Iron [Moles/volume] in Serum or Plasma
1686
9873
1.92
108.15
3.2
2.4
umol/l
12.1
12.5
1.40
1556
9049
(3028026) IgM [Mass/volume] in Serum or Plasma
770
3329
2.47
107.74
2.8
1.8
g/l
1.5
1.4
0.26
694
2998
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2807
19201
1.74
107.66
3.8
3.1
ng/l
1857.5
1639.9
1.12
2450
16550
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1323
7182
2.03
105.52
2.2
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1085
5474
2.15
105.28
3.6
2.5
e9/l
72.2
69.1
1.90
846
4121
(3017181) Myelocytes/100 leukocytes in Blood
1024
5056
2.19
104.93
5.8
4.0
%
0.9
0.9
0.12
399
1450
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1498
8511
1.95
104.76
3.3
2.5
%
21.5
21.9
0.62
1295
7148
(3007853) Bacteria identified in Skin by Aerobe culture
1295
7007
2.03
104.10
2.0
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5058
40862
1.75
103.77
6.4
4.8
e6/l
1547.0
2322.6
0.43
78
595
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1314
7167
2.01
103.20
2.3
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
964
4697
2.21
101.92
2.0
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1676
10043
1.86
98.91
5.2
3.1
mmol/l
0.8
0.8
2.32
1573
9279
(3037467) Urinalysis macro (dipstick) panel - Urine
5129
41950
1.73
96.73
6.5
4.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2758
19220
1.69
95.87
3.2
2.5
u/l
58.0
58.3
0.09
2570
17617
(3002179) Metamyelocytes/100 leukocytes in Blood
931
4597
2.17
94.79
5.3
3.8
%
0.7
0.6
0.10
288
1041
(3021440) Promyelocytes/100 leukocytes in Blood
961
4815
2.14
94.23
5.8
4.0
%
0.2
0.1
0.33
375
1347
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2399
16199
1.71
93.12
2.7
2.3
mg/l
3.2
3.0
2.94
2066
13746
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3267
23954
1.65
92.33
5.2
3.9
ng/l
49.0
91.5
1.13
2554
17209
(3042936) Bacteria identified in Isolate by Culture
1467
8597
1.88
92.03
2.3
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
417
1427
3.04
91.69
2.1
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3460
25792
1.64
91.17
12.0
9.8
inr
1.3
1.3
0.77
986
7196
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
163
279
5.95
90.82
3.5
2.4
%
38.1
39.2
0.16
48
107
(3021589) Normoblasts [#/volume] in Blood
3475
26002
1.63
89.65
15.7
9.7
e9/l
0.0
0.0
0.52
2977
21102
(3018418) pH of Serum or Plasma
2679
18786
1.67
89.28
6.8
3.9
ph
7.4
7.4
0.71
548
3534
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
399
1375
3.01
86.59
2.2
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
241
610
4.05
84.42
1.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1032
5516
2.01
84.41
11.4
6.6
mmol/l
11.2
10.4
2.29
975
5211
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
330
1033
3.30
84.25
2.2
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
102
113
9.14
83.68
2.6
1.8
e6/l
132.2
143.5
0.16
58
54
(3014148) Varicella zoster virus Ab [Titer] in Serum
225
552
4.17
82.20
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6586
58978
2.06
81.94
27.3
15.2
mg/l
22.5
24.8
7.85
5771
47312
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2667
19002
1.63
81.55
2.6
2.1
u/l
188.8
218.5
0.92
2518
17724
(3002582) Erythrocytes [#/volume] in Urine
2655
18899
1.63
81.46
4.8
3.3
e6/l
44.0
89.8
3.52
2179
14460
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
656
2978
2.32
81.38
1.9
1.7
g/l
1.5
1.5
0.43
573
2523
(3018095) Leukocytes [#/volume] in Urine
2986
21912
1.61
80.62
5.4
3.8
e6/l
88.9
109.7
0.97
2299
15531
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
429
1599
2.79
80.56
2.6
1.5
g/l
0.2
0.2
2.60
403
1497
(3026008) Bacteria identified in Urine by Culture
2811
20334
1.62
80.52
4.0
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3353
25325
1.59
79.96
2.8
2.2
nmol/l
79.8
78.6
1.26
2997
22400
(3006245) CD3-CD19+ cells/100 cells in Blood
120
172
7.07
79.40
2.6
1.9
%
9.3
10.7
0.52
105
161
(3025159) Blasts/100 leukocytes in Blood
877
4513
2.07
79.35
5.8
4.0
%
0.1
0.4
1.35
311
1128
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
316
1001
3.25
79.09
1.7
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
435
1650
2.74
78.97
2.6
1.5
g/l
1.2
1.2
1.26
416
1541
(3020630) Protein [Mass/volume] in Serum or Plasma
999
5397
1.98
78.90
3.9
2.5
g/l
65.4
66.2
2.16
909
4814
(3030467) Casts [#/volume] in Urine by Automated count
2467
17353
1.63
78.78
4.5
3.2
e6/l
0.4
0.5
0.50
1979
13065
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
120
174
6.99
78.57
2.7
1.9
%
33.7
29.0
1.82
111
166
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
184
401
4.68
78.19
1.9
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
402
1472
2.83
78.03
1.7
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1042
5738
1.95
77.77
1.9
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
2202
15100
1.65
77.55
11.4
6.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1951
12988
1.68
76.95
2.2
1.7
mg/l
1.4
1.3
0.22
1516
9987
(3026493) Urate [Moles/volume] in Serum or Plasma
2264
15681
1.64
76.40
4.3
2.6
umol/l
3724.5
5295.8
1.14
1966
13328
(40760892) CBC W Ordered Manual Differential panel - Blood
1873
12372
1.69
75.91
7.6
4.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
274
815
3.45
75.82
2.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1367
8273
1.80
75.62
1.9
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
268
791
3.48
75.06
1.7
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
117
174
6.82
74.83
31.0
33.0
ug/l
7.2
7.5
0.58
97
160
(3000850) Epithelial cells [#/volume] in Urine
1974
13294
1.66
73.96
3.6
2.6
e6/l
5.9
5.7
0.10
1775
11581
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
743
3699
2.12
73.11
1.7
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1534
9689
1.74
72.87
2.6
2.0
s
29.7
29.8
0.44
1485
9379
(3036481) Cortisol [Moles/volume] in Serum or Plasma
973
5345
1.94
72.81
2.3
2.2
nmol/l
361.4
378.9
1.64
895
4889
(3026782) Osmolality of Urine
1867
12445
1.67
72.55
4.0
2.8
mosm/kgh2o
525.8
543.2
3.03
1662
10539
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1040
5854
1.90
72.29
5.2
3.7
kpa
5.9
5.8
0.35
1011
5665
(3004588) Protein electrophoresis panel - Serum or Plasma
848
4478
2.01
71.02
3.8
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3298
25280
1.55
70.66
3.8
2.8
ug/l
173.1
132.1
4.19
3031
23093
(3021879) Hepatitis B virus core Ab [Presence] in Serum
733
3684
2.10
70.23
1.6
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
235
668
3.60
69.69
2.0
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3741
29541
1.54
69.58
5.1
3.9
estimate
0.0
0.0
1.08
785
5436
(3002032) Base excess in Venous blood by calculation
1028
5842
1.88
69.16
5.3
3.7
mmol/l
1.9
1.9
0.09
856
4731
(3012544) pH of Venous blood
1056
6060
1.87
68.88
5.2
3.7
ph
7.4
7.4
0.43
11
28
(3044640) Blood type and Crossmatch panel - Blood
2661
19534
1.57
68.57
3.4
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3742
29629
1.53
68.17
6.9
5.2
estimate
0.0
0.0
0.80
796
5482
(3009261) Glucose [Presence] in Urine by Test strip
3770
29958
1.53
67.12
5.2
3.9
estimate
0.0
0.0
1.72
777
5383
(3028433) Virus identified in Specimen by Culture
112
181
6.27
66.15
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3597
28371
1.52
65.82
5.3
4.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1270
7823
1.75
65.12
8.2
6.5
mmol/l
104.1
104.3
0.70
1233
7640
(36304419) Bacteria [Presence] in Urine
2336
16803
1.57
64.98
4.4
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
914
5167
1.88
62.06
9.0
7.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2086
14837
1.57
59.96
3.1
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
293
1044
2.88
59.70
2.0
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1595
10700
1.63
58.52
2.0
1.4
g/l
2.3
2.5
1.73
1025
6250
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3330
26273
1.49
58.12
2.2
2.0
pmol/l
93.4
95.0
1.08
1746
13332
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2506
18673
1.52
57.73
4.7
3.1
u/l
34.7
34.7
0.00
2369
17602
(3024354) Oxygen [Partial pressure] in Venous blood
853
4821
1.87
57.72
4.4
3.1
kpa
4.5
4.5
0.17
828
4641
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
862
4900
1.86
57.25
5.0
3.5
ng/l
101.8
91.2
2.08
729
4128
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
88
129
6.89
57.06
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1579
10630
1.62
56.88
3.7
2.8
e6/l
1.3
1.5
0.38
1014
6050
(3000494) Fungus identified in Specimen by Culture
1104
6768
1.74
56.88
1.8
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
264
922
2.93
55.78
1.5
1.4
u/ml
109.8
120.4
0.70
63
189
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1150
7167
1.72
55.75
1.8
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
285
1038
2.82
55.74
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2796
21433
1.49
55.55
4.4
3.3
mmol/l
2.3
2.4
2.42
2394
18396
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
284
1039
2.80
55.08
1.5
1.4
u/ml
19.8
18.8
—
7
24
(3019550) Sodium [Moles/volume] in Serum or Plasma
6637
61065
1.84
54.86
28.9
17.8
mmol/l
139.4
139.6
7.34
6501
59429
(21494814) CD8 cells/100 lymphocytes in Specimen
112
218
5.20
54.39
2.1
2.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
924
5456
1.79
54.01
7.1
6.4
mmol/l
1.3
1.4
0.84
881
5249
(3033658) Prothrombin time (PT) actual/Normal
2110
15330
1.53
53.93
5.5
3.8
%
88.7
88.2
0.42
2057
14938
(3004809) Band form neutrophils/100 leukocytes in Blood
280
1030
2.79
53.74
4.6
3.5
%
1.2
1.6
1.07
235
783
(3037692) Legionella sp identified in Specimen by Organism specific culture
101
182
5.61
53.37
1.7
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
520
2539
2.13
53.29
2.1
1.6
u/ml
12.4
18.2
0.56
20
69
(3023103) Potassium [Moles/volume] in Serum or Plasma
6640
61196
1.83
53.24
29.3
18.0
mmol/l
4.0
4.0
3.20
6499
59448
(3037522) Nuclear Ab [Titer] in Serum
1178
7493
1.68
52.65
1.5
1.3
titre
640.1
515.0
1.21
273
1624
(3009343) pH of Capillary blood
717
3951
1.90
52.23
4.8
3.6
ph
7.4
7.4
0.07
96
492
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
724
4004
1.90
52.16
4.9
3.6
kpa
5.1
5.2
3.02
662
3664
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1086
6775
1.71
52.16
4.4
2.6
umol/l
7.6
8.8
1.27
968
5829
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
124
275
4.57
51.63
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
132
309
4.33
51.33
1.2
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2074
15144
1.51
51.26
1.7
1.6
nmol/l
20.5
20.4
0.13
1796
12828
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
270
999
2.77
51.24
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
693
3808
1.90
50.87
4.7
3.6
mmol/l
1.4
1.9
2.74
510
2823
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1462
9891
1.60
50.86
4.0
3.0
e6/l
3.1
2.7
0.72
902
5370
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
451
2125
2.20
50.56
3.0
2.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
520
2590
2.08
50.51
2.3
1.9
ug/l
5.6
2.2
0.62
461
2243
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
257
937
2.81
50.16
1.3
1.2
u/ml
279.0
267.2
0.26
170
561
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1747
12368
1.54
49.60
4.9
3.9
ng/l
336.1
423.0
0.32
1416
10063
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
247
887
2.85
49.59
1.6
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4010
33437
1.44
48.85
3.1
2.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
226
780
2.96
48.78
1.6
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
117
260
4.56
48.61
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
342
1462
2.40
48.19
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6073
54989
1.58
48.09
22.9
14.4
ml/min/173m2
75.3
77.5
10.64
5292
45368
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
695
3894
1.87
47.92
1.9
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
191
608
3.20
47.39
2.2
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1329
8938
1.59
46.97
29.1
27.1
inr
1.4
1.4
0.36
181
1259
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
316
1325
2.45
46.45
1.7
1.3
mg/l
575.3
531.0
0.86
305
1249
(3028679) Herpes simplex virus Ab [Presence] in Serum
109
239
4.61
46.05
1.1
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
53
55
9.70
45.63
2.2
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5166
45412
1.46
45.43
4.5
4.1
pmol/l
15.0
14.9
1.42
4644
40830
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1121
7293
1.63
45.28
7.7
6.7
kpa
5.0
5.1
1.10
1076
6937
(3037756) Immunofixation for Serum or Plasma
321
1374
2.40
45.08
2.2
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
411
1953
2.17
45.04
1.5
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1119
7289
1.63
44.95
7.7
6.7
kpa
11.7
12.2
2.71
1076
6927
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
177
563
3.20
43.99
2.2
1.7
—
—
—
0
0
(44806118)
191
636
3.06
43.93
2.1
1.3
—
—
—
0
0
(44790049)
191
636
3.06
43.93
2.1
1.3
—
—
—
0
0
(44790048)
191
636
3.06
43.93
2.1
1.3
—
—
—
0
0
(44790047)
191
636
3.06
43.93
2.1
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
91
179
5.13
43.71
2.2
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
268
1076
2.55
43.21
1.7
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1763
12820
1.49
43.10
1.9
1.8
nmol/l
1184.5
1169.0
0.27
1323
9532
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
65
8.52
42.91
4.5
5.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1108
7279
1.61
42.81
7.7
6.7
mmol/l
1.2
1.1
0.34
903
5651
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
158
477
3.36
42.75
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
282
1167
2.47
42.65
1.7
1.3
mmol/l
3.7
3.8
0.45
265
1084
(3045142) Bone marrow Pathology biopsy report
197
679
2.95
42.64
1.6
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
90
182
4.99
41.90
2.3
2.0
u/ml
685.8
76013.4
—
9
24
(40768804) Tissue Pathology biopsy report
3009
24266
1.40
41.76
2.4
2.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
74
126
5.92
41.53
5.5
5.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
161
502
3.26
41.37
2.3
2.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1008
6527
1.63
41.19
8.1
7.0
%
95.5
95.6
0.07
975
6265
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
330
1491
2.27
40.90
5.9
3.2
mg/l
1.8
1.6
4.54
305
1338
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
540
2935
1.91
40.71
5.8
3.9
mmol/l
24.3
24.2
0.30
475
2627
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
423
2115
2.06
40.52
6.0
3.1
mg/l
36.5
50.4
1.20
349
1725
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
914
5800
1.66
40.41
2.4
2.1
g/l
0.2
0.2
0.95
852
5375
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5956
54247
1.50
40.24
5.5
4.9
mu/l
2.0
2.1
0.90
5447
49108
(3034860) Kappa light chains.free [Mass/volume] in Serum
422
2116
2.05
40.11
6.0
3.1
mg/l
81.8
83.8
0.02
345
1730
(40761511) CBC panel - Blood by Automated count
6532
60751
1.64
40.00
23.2
14.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6659
62244
1.70
39.92
17.2
10.6
u/l
25.2
25.3
0.14
6428
59693
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
412
2062
2.06
39.35
5.9
3.1
ratio
2.7
2.4
0.20
36
153
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
523
2849
1.90
39.12
3.6
2.7
%
0.7
0.7
0.81
501
2733
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2814
22648
1.39
38.56
5.6
4.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
272
1170
2.38
37.78
1.8
1.4
e6/l
18.3
26.4
0.52
209
903
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
158
515
3.11
37.73
1.4
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
272
1171
2.37
37.71
1.9
1.5
e6/l
338.3
1266.7
2.03
219
955
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
341
1614
2.17
37.69
2.4
1.4
iu/ml
14.6
17.6
0.18
14
39
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
475
2537
1.93
37.69
3.9
2.2
g/l
7.3
7.5
0.94
335
1864
(40760888) Immunoglobulin light chains.free panel - Serum
336
1585
2.17
37.45
5.9
3.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
473
2534
1.93
37.18
3.9
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
186
671
2.82
37.07
5.3
4.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
472
2532
1.92
36.95
3.9
2.2
g/l
3.7
3.8
0.20
315
1791
(3024471) HLA-A [Type]
75
145
5.21
36.77
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
881
5667
1.63
36.70
2.9
2.4
u/l
43.5
46.5
0.09
770
4822
(3024932) HLA-DR beta [Type]
73
139
5.29
36.41
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
2087
16093
1.41
36.20
5.7
4.3
estimate
0.0
0.0
0.16
766
5291
(3004119) Hemoglobin [Mass/volume] in Venous blood
641
3807
1.75
36.04
4.2
3.3
g/l
125.1
127.8
2.36
626
3706
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
446
2368
1.94
35.99
3.8
2.2
g/l
3.1
3.1
0.03
318
1829
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4263
36917
1.37
35.95
4.0
3.0
u/l
59.0
49.9
5.10
3951
33910
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
415
2152
1.98
35.87
3.8
2.3
g/l
1.6
0.9
1.89
351
1821
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
342
1655
2.12
35.70
3.5
2.4
g/l
3.4
3.6
1.47
332
1568
(40761535) Cells panel - Urine sediment
827
5276
1.64
35.54
5.3
3.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
390
1987
2.02
35.43
1.8
1.6
titre
289.5
271.0
0.05
29
91
(3011397) Hemoglobin [Presence] in Urine by Test strip
1875
14258
1.42
34.97
4.9
3.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
153
512
3.03
34.94
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
153
512
3.03
34.94
2.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
153
512
3.03
34.94
2.1
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1349
9641
1.49
34.93
1.3
1.3
iu/ml
63.7
34.9
0.65
424
2976
(3002173) Hemoglobin [Mass/volume] in Arterial blood
911
5997
1.59
34.35
8.6
7.4
g/l
117.7
120.3
3.38
884
5776
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
354
1765
2.06
34.13
1.7
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
77
164
4.73
33.77
3.5
3.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
141
461
3.10
33.53
2.3
1.8
mg/l
3.7
4.3
1.07
131
439
(3027273) Bicarbonate [Moles/volume] in Venous blood
537
3103
1.79
33.12
4.3
3.3
mmol/l
25.3
25.2
0.26
527
3011
(3005322) IgE [Units/volume] in Serum or Plasma
552
3219
1.77
32.99
1.5
1.3
u/ml
367.7
205.9
1.68
500
2952
(4035726)
839
5475
1.60
32.73
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
543
3169
1.77
32.35
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
284
1333
2.18
32.06
1.8
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
254
1144
2.26
31.73
5.5
3.6
%
56.5
58.2
0.99
254
1144
(3022313) Gas panel - Capillary blood
498
2855
1.80
31.51
5.0
3.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
336
1696
2.03
31.31
1.6
1.6
iu/ml
6.5
5.8
0.03
75
391
(3007461) Platelets [#/volume] in Blood
6820
64732
1.69
31.27
37.6
22.4
e9/l
244.8
248.9
5.20
6669
62860
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
478
2713
1.81
31.26
2.4
2.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
6823
64771
1.69
31.22
37.6
22.4
e9/l
7.1
6.8
4.11
6664
62671
(3016018) Differential panel - Cerebral spinal fluid
156
562
2.81
31.22
1.5
1.4
—
—
—
0
0
(4062490)
150
531
2.86
31.02
1.5
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
6822
64774
1.68
31.00
37.8
22.5
g/l
130.7
133.6
47.62
6723
63677
(3019060) Gas panel - Arterial blood
681
4276
1.65
30.98
5.3
4.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
6820
64753
1.68
30.96
37.4
22.3
pg
30.4
30.3
1.56
6724
63636
(3024731) MCV [Entitic volume]
6820
64753
1.68
30.96
37.4
22.3
fl
91.7
91.2
11.50
6723
63637
(3026361) Erythrocytes [#/volume] in Blood
6820
64760
1.68
30.85
37.6
22.4
e12/l
4.3
4.4
41.63
6665
62672
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
398
2141
1.91
30.84
2.4
2.2
ug/l
447.0
607.6
0.56
363
2015
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
143
499
2.90
30.36
1.8
1.5
—
—
—
0
0
(3013512) EKG study
2286
18332
1.36
30.00
5.2
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
444
2495
1.83
29.99
2.1
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
331
1690
2.00
29.88
2.9
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
80
194
4.16
29.83
1.8
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
608
3754
1.67
29.48
2.4
2.4
au/ml
18.8
24.3
0.68
22
174
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
856
5744
1.55
29.43
2.7
2.4
ug/l
6.9
6.8
0.05
716
4877
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
425
2378
1.84
29.10
4.0
2.2
g/l
10.2
10.2
0.00
342
1973
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
800
5303
1.57
29.01
5.8
3.7
mmol/l
1.2
1.2
0.43
731
4586
(3028626) Oxygen [Partial pressure] in Capillary blood
292
1447
2.06
28.63
3.6
3.0
kpa
8.1
8.0
0.36
273
1334
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
434
2465
1.81
28.29
5.3
3.9
mmol/l
24.5
24.9
1.58
397
2236
(3028192) IgG subclass 2 [Mass/volume] in Serum
145
530
2.77
28.27
1.5
1.3
g/l
2.4
2.9
3.48
113
361
(3024139) IgG subclass 3 [Mass/volume] in Serum
145
530
2.77
28.27
1.5
1.3
g/l
0.3
0.4
2.21
112
362
(3027135) IgG subclass 1 [Mass/volume] in Serum
145
531
2.77
28.18
1.5
1.3
g/l
6.0
6.9
1.82
114
361
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
49
84
5.87
27.37
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
181
752
2.44
27.22
2.7
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
277
1374
2.06
27.09
1.5
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
553
3405
1.67
27.04
1.3
1.3
au/ml
91.7
51.8
0.83
12
148
(3022145) Colonoscopy Study observation
938
6540
1.50
26.82
1.4
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
312
1624
1.96
26.66
4.0
3.1
mmol/l
24.2
25.1
2.95
277
1410
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
398
2248
1.81
26.41
3.5
2.9
u/ml
0.3
0.3
0.24
243
1273
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
22
13
16.97
26.33
2.5
2.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5848
54199
1.38
26.32
7.0
6.0
mmol/mol
40.7
40.1
5.28
5332
49548
(3048689) Calprotectin [Mass/mass] in Stool
947
6646
1.49
26.18
3.0
2.1
ug/g
142.2
142.5
0.01
739
5179
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
276
1386
2.03
26.11
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
276
1386
2.03
26.11
1.4
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
617
3941
1.62
26.08
9.4
8.3
%
0.7
0.7
1.64
612
3907
(3023410) Appearance of Cerebral spinal fluid
135
497
2.75
26.00
2.1
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5250
47909
1.33
25.87
30.9
18.5
%
14.0
13.8
21.59
5178
46781
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
412
2368
1.78
25.79
2.2
1.8
u/l
37.9
38.6
0.28
354
2062
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
185
797
2.35
25.68
6.2
6.3
mg/l
11.9
12.0
0.08
167
727
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
64
147
4.38
25.65
1.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
929
6524
1.48
25.56
4.6
3.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
616
3953
1.61
25.52
9.3
8.2
%
1.4
1.3
0.45
611
3922
(3041096) Erythrocytes [Presence] in Urine by Automated
1953
15592
1.34
25.51
4.8
3.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2329
19077
1.32
25.48
4.0
3.1
mmol/l
7.1
7.2
0.51
1947
15837
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
78
209
3.76
25.40
3.3
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1229
9110
1.42
25.36
1.3
1.2
u/ml
15.6
13.7
0.19
401
3400
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
112
378
2.99
25.31
1.8
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
288
1486
1.98
25.24
2.3
1.9
mg/l
12.0
11.8
0.16
267
1359
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
152
607
2.54
24.90
2.9
3.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2226
18165
1.32
24.87
4.1
3.2
mg/l
664.2
360.0
1.67
1502
11273
(21494890) Protein electrophoresis panel - 24 hour Urine
158
644
2.48
24.79
3.6
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2335
19189
1.32
24.79
4.8
3.9
mg/mmol
14.0
9.3
3.18
1551
11885
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
357
1989
1.84
24.77
3.6
2.1
g/l
37.4
37.4
0.02
299
1672
(3017354) Segmented neutrophils/100 leukocytes in Blood
157
641
2.48
24.55
4.2
3.5
%
55.6
59.3
1.13
109
397
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
21
13
16.20
24.55
2.2
2.7
—
—
—
0
0
(3019225) pH of Specimen
918
6500
1.47
24.15
6.0
4.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
342
1897
1.84
24.07
4.0
2.2
g/l
0.1
0.0
0.28
316
1713
(3015171) Extractable nuclear Ab [Units/volume] in Serum
380
2178
1.78
24.01
1.3
1.2
u/ml
0.2
1.2
3.14
39
205
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
292
1544
1.93
23.83
3.5
2.4
%
200.2
197.6
0.18
279
1470
(40768797) Stomach Pathology biopsy report
1123
8278
1.42
23.77
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
372
2129
1.79
23.62
2.8
2.0
s
22.1
21.4
0.90
340
1880
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
63
153
4.14
23.52
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1736
13764
1.34
23.41
1.7
1.7
pmol/l
22597305.9
27970471.1
0.15
1394
11212
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
519
3261
1.64
23.39
9.3
8.5
mmol/l
24.5
24.4
0.31
477
3027
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
236
1166
2.06
23.36
1.4
1.2
titre
66.0
191.0
—
10
31
(3052851) Hemolysis interference index of Serum or Plasma
343
1926
1.82
23.21
3.8
3.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
376
2173
1.77
23.10
5.1
2.8
g/l
0.3
0.3
0.06
195
863
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
302
1632
1.89
23.08
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
100
334
3.02
23.05
1.9
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
614
4033
1.57
22.98
3.6
3.0
e9/l
4.0
4.1
0.86
433
3016
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
87
271
3.24
22.56
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
90
287
3.16
22.45
5.6
3.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
187
858
2.21
22.42
1.6
1.6
g/l
0.4
0.8
9.49
147
639
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
99
335
2.98
22.31
1.9
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
274
1452
1.92
22.23
2.7
2.2
g/l
123.8
127.3
1.11
190
1049
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
93
305
3.08
22.13
2.4
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
93
305
3.08
22.13
2.4
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
93
305
3.08
22.13
2.4
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
93
305
3.08
22.13
2.4
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
267
1412
1.92
21.80
5.2
3.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
612
4074
1.55
21.56
8.1
6.7
mmol/l
24.9
24.6
1.17
576
3799
(3029634) Reagin Ab [Titer] in Serum by VDRL
154
662
2.35
21.55
2.7
1.9
titre
16.1
3.5
—
9
10
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
23
21
10.98
21.54
3.4
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
273
1461
1.90
21.51
1.8
1.6
e6/l
19890.6
12403.0
1.03
212
1039
(3023420) DNA double strand Ab [Units/volume] in Serum
138
567
2.46
21.34
2.5
1.4
iu/ml
26.7
23.6
0.17
12
27
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6067
57049
1.35
21.09
5.3
4.7
mmol/l
6.0
6.0
2.82
5480
51321
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
58
144
4.05
21.05
3.9
3.4
mg/l
7.5
7.6
0.03
45
122
(3042631) Mycobacterium sp identified in Specimen
184
862
2.16
20.97
2.9
2.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
50
111
4.53
20.96
2.8
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
114
431
2.67
20.93
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1561
12360
1.33
20.88
1.3
1.3
u/ml
1.9
1.8
0.07
381
3194
(3044889) 12 lead EKG panel
4601
41737
1.27
20.88
4.8
4.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
301
1679
1.83
20.83
3.2
2.2
%
93.0
90.8
0.87
291
1570
(3003181) Sodium [Moles/volume] in Urine
228
1162
1.99
20.75
1.4
1.3
mmol/l
58.1
62.8
1.11
188
932
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
58
146
4.00
20.67
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
231
1185
1.98
20.64
3.5
2.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
57
142
4.04
20.60
1.3
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
216
1084
2.02
20.53
1.7
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
39
71
5.52
20.50
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
55
134
4.13
20.48
1.3
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
307
1736
1.80
20.31
4.0
2.3
g/l
0.0
0.0
0.00
286
1586
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
130
535
2.46
20.06
1.2
1.1
—
3.9
—
0
8
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
229
1183
1.97
20.06
1.5
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5831
54623
1.32
19.98
4.5
4.0
mmol/l
1.3
1.3
5.62
5248
49152
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
310
1771
1.78
19.82
3.9
2.2
g/l
0.0
0.0
0.50
286
1594
(3016650) Hepatitis A virus Ab [Presence] in Serum
181
863
2.12
19.74
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
186
898
2.10
19.64
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
56
143
3.94
19.59
1.3
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
89
306
2.93
19.55
1.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
89
306
2.93
19.55
1.6
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
498
3253
1.57
19.04
4.2
2.8
e6/l
0.3
0.3
0.15
489
3181
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
805
5807
1.43
18.95
3.6
3.0
ng/l
247.4
219.7
0.42
728
5294
(3012501) Base excess in Blood by calculation
258
1415
1.85
18.87
5.3
4.2
mmol/l
2.6
2.7
0.07
193
962
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
69
209
3.32
18.78
1.2
1.1
miu/ml
2101.1
1619.8
1.97
69
209
(40767503) Oxygen content in Capillary blood by calculation
249
1354
1.87
18.71
3.5
2.5
%
15.6
16.0
1.03
140
704
(3028271) Lactate [Moles/volume] in Capillary blood
199
1005
2.01
18.62
2.2
1.9
mmol/l
1.6
1.7
0.85
194
982
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
134
581
2.33
18.45
2.4
1.6
titre
4363.6
1053.3
0.88
11
18
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
43
94
4.60
18.40
1.4
1.1
—
—
—
0
0
(3020891) Body temperature
405
2539
1.63
18.39
5.6
4.5
—
—
—
0
0
(3010421) pH of Blood
289
1654
1.78
18.39
5.3
4.1
ph
7.4
7.4
0.31
256
1382
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
513
3406
1.54
18.24
10.6
9.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
188
940
2.03
18.10
2.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1618
13103
1.30
18.03
5.6
4.4
kg/l
1.0
1.0
0.26
236
2058
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
257
1429
1.83
18.00
1.4
1.2
u/ml
12.6
5.2
0.78
34
147
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
120
502
2.41
17.92
1.7
1.6
u/ml
30.8
22.8
0.66
17
110
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
274
1557
1.79
17.87
1.4
1.2
u/ml
63.6
46.6
0.37
21
93
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
57
158
3.63
17.78
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
421
2690
1.60
17.69
5.7
5.0
%
1.6
1.6
0.15
403
2521
(40768443) Skin Pathology biopsy report
424
2715
1.60
17.65
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
83
291
2.87
17.64
2.6
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
257
1445
1.81
17.37
1.4
1.2
u/ml
8.3
6.6
0.31
52
228
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1486
11960
1.30
17.24
3.7
3.0
mmol/l
2.5
2.5
0.61
1305
10382
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
110
453
2.45
17.02
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
54
149
3.64
16.97
1.1
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
44
106
4.17
16.68
1.7
1.6
au/ml
64.7
133.3
0.60
11
12
(3020876) Protein [Mass/time] in 24 hour Urine
121
525
2.33
16.67
2.5
1.9
g/24h
0.5
1.3
—
6
25
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
161
3.50
16.57
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
217
1176
1.87
16.52
1.3
1.2
u/ml
3.4
4.4
0.18
15
84
(3024891) Influenza virus A+B Ag [Presence] in Specimen
254
1445
1.78
16.52
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
241
1353
1.81
16.39
1.2
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
21
25
8.42
16.24
3.8
5.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
163
807
2.04
16.16
1.7
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
29
50
5.82
16.15
1.2
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
410
2665
1.57
16.02
5.8
5.0
%
0.8
0.9
1.74
391
2499
(3005988) Vibrio sp identified in Specimen by Organism specific culture
163
810
2.04
16.01
1.7
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
670
4817
1.43
15.98
3.6
2.7
ml/min/173m2
56.0
63.4
5.21
303
1959
(3025468) Yersinia sp identified in Specimen by Organism specific culture
162
804
2.04
15.96
1.7
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6149
58458
1.31
15.93
5.5
5.0
mmol/l
2.6
2.7
8.10
5570
53161
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
34
69
4.95
15.90
1.3
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
195
1035
1.91
15.85
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
88
338
2.62
15.77
2.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
164
824
2.01
15.63
1.7
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
128
585
2.21
15.62
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
302
1833
1.68
15.59
1.5
1.4
ug/g
273.2
270.4
0.08
173
1086
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
161
805
2.02
15.56
1.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6018
57102
1.29
15.46
5.0
4.5
mmol/l
4.5
4.6
7.55
5483
52200
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
159
794
2.02
15.42
3.7
2.2
pg
32.5
32.6
0.16
159
786
(3039162) Centromere protein B Ab [Units/volume] in Serum
140
667
2.12
15.40
1.3
1.2
u/ml
91.9
43.4
—
7
41
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
34
71
4.81
15.39
1.1
1.1
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
1.1
2.4
0.43
17
22
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
1.2
1.7
0.19
15
23
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
0.8
2.4
0.89
16
17
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
2.8
3.4
0.13
18
22
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
2.7
4.1
0.35
18
19
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
2.4
3.2
0.25
18
18
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
0.9
1.2
0.21
17
20
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
23
33
6.99
15.24
1.7
1.5
mg/l
0.6
1.0
0.31
17
21
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1098
8608
1.32
15.23
1.6
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
84
321
2.64
15.22
1.5
1.6
u/l
5.3
6.5
1.00
68
274
(3024522) Salmonella sp identified in Specimen by Organism specific culture
161
812
2.00
15.20
1.7
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
261
1534
1.73
15.18
1.4
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
69
238
2.92
15.16
2.8
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
69
238
2.92
15.16
2.8
2.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
357
2279
1.60
15.07
4.3
3.9
mmol/l
1.4
1.4
0.00
350
2238
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
204
1117
1.85
15.07
1.3
1.2
u/ml
61.4
44.2
0.57
22
129
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
69
239
2.90
15.05
2.8
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
121
550
2.22
14.98
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
129
602
2.16
14.97
1.4
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
65
219
2.99
14.90
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
148
732
2.04
14.76
1.9
1.6
%
57.7
60.9
0.42
103
455
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
242
1406
1.75
14.68
1.4
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
313
1953
1.63
14.53
4.6
4.1
mmol/l
3.9
3.9
0.69
290
1818
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
23
35
6.59
14.45
1.7
1.5
mg/l
1.3
1.5
0.08
17
21
(3009214) Lutropin [Units/volume] in Serum or Plasma
213
1202
1.79
14.29
1.7
1.4
u/l
10.7
11.4
0.30
179
982
(40757373) Influenza virus identified in Isolate
43
115
3.75
14.19
2.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
42
111
3.80
14.09
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
886
6808
1.34
14.04
3.8
3.9
ug/l
11.2
22.5
2.00
727
5550
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
20
27
7.42
13.96
1.3
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
185
1007
1.86
13.96
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
81
318
2.56
13.94
1.4
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5956
56627
1.27
13.84
5.0
4.4
mmol/l
1.5
1.5
4.65
5403
51421
(3013727) Leukocytes other/100 leukocytes in Blood
61
207
2.96
13.83
6.4
3.3
%
47.0
54.1
1.62
61
198
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
65
229
2.85
13.79
2.7
1.8
ug/l
51.8
58.5
0.41
65
222
(3009871) Measles virus Ab [Titer] in Serum
48
144
3.35
13.36
1.5
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
999
7881
1.31
13.12
1.3
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
40
108
3.72
13.04
1.8
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
273
1697
1.63
12.90
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
500
3543
1.44
12.88
3.3
3.2
pmol/l
4.3
4.4
4.31
443
3109
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
96
423
2.29
12.87
1.4
1.3
titre
562.0
362.2
—
5
40
(3024928) Oxygen saturation in Venous blood
216
1264
1.73
12.82
4.0
3.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
157
836
1.90
12.72
2.7
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
274
1717
1.62
12.54
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
275
1725
1.62
12.53
1.3
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
27
56
4.84
12.35
2.9
2.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
46
143
3.23
12.13
2.2
2.0
mg/l
7.8
9.6
1.35
39
119
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
147
780
1.90
12.06
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
20
32
6.26
11.99
1.3
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
170
948
1.81
11.93
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
525
3805
1.41
11.93
1.9
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
85
368
2.32
11.90
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
130
666
1.97
11.84
1.2
1.2
u/l
60.6
59.0
0.09
78
441
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
89
396
2.26
11.70
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
89
396
2.26
11.70
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
89
397
2.26
11.63
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
189
1096
1.74
11.62
4.9
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5535
52487
1.22
11.58
26.5
16.4
%
38.2
39.1
9.41
3607
35388
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
144
772
1.88
11.47
1.1
1.1
au/ml
1.8
12.4
—
5
41
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
952
7609
1.29
11.23
4.7
4.6
%
32.7
33.1
0.47
646
4996
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
51
177
2.89
11.19
1.1
1.2
%
12.6
34.6
1.23
12
22
(40765096) Chromosome analysis panel by Banding
50
172
2.92
11.14
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
150
823
1.84
11.12
2.2
2.1
mg/l
24.9
26.9
0.16
40
202
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
87
394
2.22
10.99
1.3
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
65
260
2.51
10.85
11.5
4.8
u/ml
100.8
96.7
0.02
27
45
(1761482) Bacteria [#/volume] in Urine by Culture
269
1744
1.56
10.71
5.7
4.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
155
871
1.80
10.65
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
94
445
2.13
10.65
1.3
1.2
titre
306.7
163.0
0.67
18
86
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
94
445
2.13
10.65
1.3
1.2
titre
145.0
106.0
—
6
15
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
86
394
2.20
10.58
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
86
394
2.20
10.58
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
79
350
2.27
10.54
1.3
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
98
474
2.08
10.50
1.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
75
326
2.31
10.46
1.2
1.1
u/l
22.0
30.1
0.59
60
242
(3003434) Protein [Mass/volume] in Pleural fluid
160
915
1.77
10.38
1.6
1.5
g/l
30.7
31.4
0.26
143
818
(3052592) Norovirus Ag [Presence] in Stool
40
127
3.16
10.25
1.3
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
38
117
3.26
10.23
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1805
15627
1.20
10.18
1.4
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
52
193
2.71
10.11
1.5
1.2
g/l
0.6
0.3
—
7
12
(3003327) Ova and parasites identified in Stool by Light microscopy
266
1745
1.54
10.08
1.8
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
82
378
2.18
9.96
1.5
1.1
mg/l
46.6
42.1
0.45
68
315
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
74
327
2.28
9.95
1.2
1.1
u/l
87.2
89.1
0.06
61
247
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
31
85
3.66
9.95
1.3
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
241
1553
1.57
9.89
1.3
1.2
titre
396.0
978.8
—
5
49
(3000330) Specific gravity of Urine by Test strip
457
3342
1.39
9.87
5.1
3.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
131
717
1.84
9.84
1.2
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
80
367
2.19
9.84
1.3
1.1
mg/l
312.0
272.3
0.80
67
319
(3051651) Icteric interference index of Serum or Plasma
80
367
2.19
9.84
5.4
3.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
63
261
2.43
9.80
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
391
2787
1.43
9.79
2.1
1.9
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
65
274
2.38
9.74
1.3
1.3
%
73.0
57.4
—
6
32
(3045462) Protein/Creatinine [Ratio] in Urine
19
36
5.29
9.62
4.2
3.1
g/mol
26.2
47.9
0.62
19
29
(3023183) Ammonium ion [Moles/volume] in Plasma
196
1215
1.63
9.47
3.2
2.6
umol/l
32.8
34.1
0.30
166
1016
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
137
771
1.79
9.42
1.3
1.2
u/ml
4.5
4.1
0.10
64
328
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
74
335
2.22
9.42
1.3
1.3
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
14
20
7.01
9.28
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
14
20
7.01
9.28
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
14
20
7.01
9.28
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
14
20
7.01
9.28
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
50
192
2.61
9.13
1.7
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
38
126
3.03
9.09
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
64
277
2.32
9.07
1.3
1.1
u/l
1.1
1.1
0.07
30
136
(3012441) Differential panel - Pleural fluid
125
693
1.82
9.05
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
113
607
1.87
9.04
4.0
3.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
131
737
1.79
9.04
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
52
205
2.55
9.01
1.1
1.1
ng/l
239.0
457.8
0.58
16
50
(3023199) Leukocytes [#/volume] in Pleural fluid
139
797
1.76
8.99
1.6
1.5
e6/l
4879.3
2043.6
0.51
98
582
(40761536) Microorganisms panel - Urine sediment
658
5159
1.30
8.94
5.8
4.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
166
1003
1.67
8.89
1.3
1.3
u/l
64.4
43.4
0.72
140
871
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
303
2098
1.46
8.89
1.6
1.6
—
—
—
0
0
(3013862) HLA-DP [Type]
14
21
6.68
8.89
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
231
1514
1.54
8.83
3.3
3.2
nmol/l
0.8
0.8
0.31
175
1148
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
73
338
2.17
8.82
1.3
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
108
578
1.88
8.76
1.5
1.4
e6/l
131468.5
115351.8
0.09
76
387
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
28
79
3.55
8.65
1.9
1.2
ng/l
87.6
75.6
0.10
19
55
(3002621) Streptococcal DNAse B [Units/volume] in Serum
22
52
4.24
8.64
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
343
2444
1.42
8.64
2.7
2.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
91
462
1.98
8.63
1.3
1.3
u/l
10.1
12.4
1.15
84
421
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
82
402
2.05
8.56
1.6
1.5
u/l
10.2
6.0
0.46
38
181
(3007566) Smooth muscle Ab [Titer] in Serum
233
1543
1.53
8.51
1.3
1.2
titre
94.2
142.8
0.56
24
128
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
26
71
3.67
8.43
15.5
12.2
mmol/l
5.9
5.6
0.10
26
71
(3022493) Free Hemoglobin [Mass/volume] in Plasma
59
255
2.32
8.42
7.1
4.1
mg/l
71.1
65.3
0.26
47
177
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2018
17892
1.18
8.39
5.0
5.2
ug/l
2.4
3.8
3.87
1798
15920
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
111
611
1.83
8.26
1.3
1.3
u/l
281.5
314.9
0.44
106
580
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
63
3.82
8.22
1.2
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
276
3923
0.69
8.18
1.7
1.7
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
21
50
4.21
8.18
2.6
3.3
mg/l
2.3
1.1
0.44
14
36
(3051611) Lipemic interference index of Serum or Plasma
118
664
1.79
8.18
4.8
3.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
68
316
2.16
8.17
5.0
3.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
23
59
3.91
8.13
1.3
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
135
792
1.72
8.10
1.2
1.2
u/ml
3.2
3.6
0.11
46
262
(3045424) Erythrocytes [Presence] in Urine
166
1029
1.63
8.08
1.5
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
124
718
1.74
7.81
1.6
1.4
e6/l
21713.3
63417.6
2.40
67
425
(3047181) Lactate [Moles/volume] in Blood
286
2010
1.44
7.80
7.2
6.0
mmol/l
1.3
1.3
0.39
258
1778
(21494755) Public health laboratory ask at order entry panel
271
3813
0.70
7.60
1.3
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
22
58
3.80
7.51
2.1
2.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
101
558
1.82
7.47
1.7
1.5
%
31.9
29.7
0.25
72
344
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
23
63
3.66
7.44
1.3
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
140
853
1.65
7.34
1.6
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
59
272
2.18
7.28
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
39
149
2.63
7.27
2.1
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
359
2660
1.37
7.23
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
502
3911
1.30
7.18
2.2
1.9
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
69
340
2.04
7.18
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
69
340
2.04
7.18
1.7
1.4
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
11
16
6.88
7.14
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
23
65
3.55
7.13
1.3
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
61
288
2.13
7.10
2.2
2.4
ml
1843.8
1892.6
0.13
52
254
(3024316) Viscosity of Plasma
14
27
5.19
6.96
3.1
1.6
mpas
1.9
1.7
—
6
18
(3030313) Adrenal Ab [Titer] in Serum
14
27
5.19
6.96
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
72
365
1.98
6.94
1.7
1.4
—
—
—
0
0
(4027681)
60
285
2.11
6.89
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
97
544
1.79
6.87
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
550
4372
1.28
6.74
2.3
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
119
712
1.68
6.72
1.7
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
30
104
2.89
6.72
1.7
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
28
5.01
6.70
1.2
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
122
736
1.67
6.68
5.3
16.2
mmol/l
7.2
7.3
0.17
101
611
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
311
2283
1.38
6.66
3.5
3.2
u/ml
90.2
2951.8
1.56
270
1937
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
173
2578
0.66
6.63
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
71
366
1.95
6.55
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
41
4.15
6.54
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
215
1485
1.46
6.49
1.3
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
60
293
2.06
6.43
1.7
2.1
mmol/l
7.8
9.4
3.00
41
229
(3022621) pH of Urine by Test strip
525
4175
1.28
6.42
3.7
3.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
212
1465
1.46
6.39
1.7
1.6
mu/l
365.1
309.0
0.88
195
1327
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
928
7856
1.21
6.39
10.1
7.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
206
1417
1.47
6.36
2.5
2.2
u/l
5160.5
4881.2
0.05
92
565
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
41
172
2.39
6.34
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
84
463
1.82
6.33
3.5
2.7
%
10.0
10.8
1.07
84
463
(36660697) Celiac disease serology panel - Serum
556
4463
1.27
6.31
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
165
1087
1.53
6.29
1.8
1.8
nmol/l
0.9
0.8
1.06
124
909
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
85
472
1.81
6.26
1.7
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
39
161
2.43
6.25
1.1
1.2
%
90.3
86.9
0.20
19
79
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
37
149
2.49
6.25
1.1
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
39
162
2.41
6.17
1.1
1.1
%
88.3
87.0
0.10
19
78
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
210
1460
1.45
6.15
2.8
2.3
ug/min
115.2
89.8
0.50
135
844
(3014271) Vancomycin [Susceptibility]
73
390
1.88
6.08
3.7
3.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
65
338
1.93
5.89
1.1
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
116
716
1.63
5.87
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
65
339
1.93
5.84
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
29
107
2.72
5.84
1.3
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
44
198
2.23
5.83
1.3
1.3
mmol/l
3.0
3.2
0.21
39
175
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
85
483
1.77
5.83
1.7
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
118
733
1.62
5.82
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
189
1305
1.46
5.77
1.3
1.3
miu/ml
188.5
225.3
0.60
59
596
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
23
75
3.07
5.75
1.2
1.2
%
58.3
46.4
0.55
13
33
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
22
70
3.15
5.73
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
228
1632
1.41
5.72
1.1
1.1
—
—
—
0
0
(4306422)
120
754
1.60
5.66
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
74
407
1.83
5.66
1.9
1.2
—
—
—
0
0
(4010399)
526
4251
1.26
5.65
1.6
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
29
109
2.67
5.64
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
76
3.03
5.63
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
76
3.03
5.63
1.4
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
76
3.03
5.63
1.4
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
77
431
1.79
5.57
2.5
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
20
61
3.28
5.57
1.4
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
23
77
2.99
5.51
2.0
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
13
29
4.49
5.50
2.2
3.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
46
217
2.13
5.45
2.7
2.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
78
443
1.77
5.39
1.2
1.2
u/ml
5.6
3.4
—
5
24
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
14
34
4.12
5.35
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
109
680
1.61
5.32
1.3
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
17
48
3.55
5.31
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
69
380
1.82
5.28
1.3
1.5
umol/l
14.9
12.7
1.28
64
359
(3045788) Cell count panel - Pleural fluid
101
620
1.64
5.27
1.7
1.5
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
11
22
5.01
5.25
1.3
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
11
22
5.01
5.25
1.3
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
203
1449
1.41
5.21
8.4
6.8
mmol/l
10.9
11.3
1.28
186
1300
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
437
3490
1.27
5.21
2.7
2.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
203
1450
1.41
5.20
8.4
6.8
mmol/l
104.4
105.0
1.09
186
1301
(3019420) Tryptase [Mass/volume] in Serum or Plasma
53
270
1.97
5.14
2.0
1.5
ug/l
10.9
8.3
0.31
48
236
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1710
15453
1.14
5.08
1.7
1.6
mmol/l
1.4
1.3
1.67
1437
12852
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1590
14300
1.14
5.08
4.3
4.5
%
22.9
22.0
1.41
776
7326
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
10
19
5.27
5.03
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
60
3.17
5.03
1.2
1.1
—
—
—
0
0
(4268621)
88
528
1.67
5.03
2.2
2.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
33
141
2.35
4.97
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
33
141
2.35
4.97
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
33
141
2.35
4.97
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
33
141
2.35
4.97
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
23
82
2.81
4.97
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
75
434
1.74
4.90
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
30
125
2.41
4.79
1.3
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
67
378
1.78
4.78
1.2
1.2
u/l
92.2
88.0
0.13
61
327
(3013762) Body weight Measured
10
20
5.01
4.77
1.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
41
196
2.10
4.75
1.2
1.2
g/l
41.9
39.5
0.46
22
98
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
100
630
1.60
4.74
1.3
1.3
—
37.6
—
0
5
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
117
765
1.54
4.72
2.7
2.4
u/ml
25.6
847.6
1.29
112
735
(3034274) Bile acid [Moles/volume] in Serum --fasting
85
515
1.66
4.71
1.9
1.9
umol/l
10.9
8.5
0.35
64
364
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
52
272
1.92
4.71
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
101
639
1.59
4.70
1.3
1.4
mosm/kgh2o
274.7
277.5
0.56
87
477
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
79
470
1.69
4.69
1.2
1.2
u/ml
45.0
70.6
—
6
19
(3020393) Adenovirus Ag [Presence] in Stool
18
58
3.11
4.63
1.5
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
33
146
2.27
4.62
1.1
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
15
43
3.49
4.60
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
79
473
1.68
4.59
1.2
1.2
u/ml
23.4
43.0
—
8
43
(4034850)
256
1940
1.33
4.58
10.9
10.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
117
772
1.52
4.55
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
112
732
1.54
4.54
1.2
1.1
%
115.7
117.3
0.19
101
648
(3032743) Legionella sp IgG Ab [Presence] in Serum
13
34
3.83
4.53
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
13
34
3.83
4.53
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
61
343
1.78
4.43
2.7
2.1
min
502.8
489.9
0.53
44
244
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
64
366
1.76
4.39
1.3
1.3
u/ml
0.4
1.2
1.12
36
171
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
39
189
2.07
4.38
1.1
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
37
176
2.11
4.36
1.7
1.2
g/l
0.3
0.3
0.07
28
138
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
59
332
1.78
4.29
1.0
1.1
iu/ml
11.7
10.5
0.08
11
86
(40761539) Cells [Type] in Urine sediment by Light microscopy
34
158
2.16
4.26
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
35
165
2.13
4.23
1.7
1.2
%
105.9
112.2
0.54
30
143
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
40
199
2.02
4.21
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
20
73
2.74
4.17
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
79
2.66
4.14
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
123
840
1.47
4.09
1.3
1.3
nmol/l
0.2
0.3
—
6
59
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
10
23
4.35
4.08
1.3
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
27
116
2.33
4.07
1.5
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
200
1491
1.35
4.04
1.1
1.1
u/ml
5.0
7.5
0.48
17
151
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
26
111
2.35
3.98
1.3
1.5
ng/l
127.5
137.2
0.14
26
111
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
76
469
1.63
3.98
1.2
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
16
53
3.02
3.96
1.6
1.6
umol/l
57.7
42.8
1.10
16
53
(3034891) Synovial lining cells/100 cells in Synovial fluid
51
282
1.81
3.95
1.8
1.5
%
2.7
3.7
—
10
67
(3014051) Protein [Presence] in Urine by Test strip
197
1477
1.34
3.85
2.7
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
122
845
1.45
3.80
1.3
1.3
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
6
5
12.01
3.76
2.3
1.6
%
3.0
6.4
—
6
5
(3020961) Endomysium IgA Ab [Titer] in Serum
314
2520
1.26
3.69
1.1
1.1
titre
342.0
174.0
—
10
58
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
17
61
2.79
3.68
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5015
48571
1.10
3.62
33.2
19.8
g/l
330.9
331.7
7.71
4976
48102
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
108
739
1.47
3.60
1.3
1.3
nmol/l
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
80
514
1.56
3.59
1.6
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
33
163
2.03
3.58
2.0
1.8
mmol/l
-0.3
0.9
1.09
33
150
(3017446) Testosterone [Moles/volume] in Serum or Plasma
426
3546
1.21
3.57
2.5
2.1
nmol/l
12.0
12.1
0.06
360
3076
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
68
421
1.62
3.56
4.0
3.3
nmol/l
230.6
140.8
0.58
68
416
(3011985) Renin [Units/volume] in Plasma
114
791
1.45
3.55
1.9
1.4
mu/l
68.0
58.4
0.19
107
698
(3036603) Volume of Urine
65
399
1.63
3.52
2.3
1.7
ml
1603.9
1870.1
0.63
20
98
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
35
178
1.97
3.52
1.7
1.5
ug/l
0.3
0.4
0.35
23
102
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
16
57
2.81
3.51
1.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
8
13
6.16
3.50
1.3
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
51
295
1.73
3.45
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
75
481
1.56
3.41
2.6
2.2
ml
790.3
626.6
2.09
49
306
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
110
766
1.44
3.38
1.3
1.3
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
13
42
3.10
3.36
1.2
1.2
ml/s/173m2
1.5
0.8
1.33
13
29
(3027923) C peptide [Moles/volume] in Serum or Plasma
54
320
1.69
3.36
1.4
1.3
nmol/l
1.3
1.2
0.19
36
244
(40763480) Human metapneumovirus Ag [Presence] in Specimen
10
27
3.71
3.35
1.3
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
60
366
1.64
3.35
1.3
1.2
u/l
33.4
25.7
0.40
53
309
(3019768) Coxiella burnetii Ab [Presence] in Serum
11
32
3.44
3.33
1.0
1.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
24
108
2.23
3.31
1.1
1.1
%
87.6
80.5
—
5
29
(3050794) Legionella sp Ab [Presence] in Serum
14
48
2.92
3.29
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
45
255
1.77
3.28
1.4
1.5
%
63.9
66.9
0.21
37
207
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
35
183
1.92
3.27
1.3
1.3
ug/l
45.1
436.8
1.24
20
95
(3009466) Valproate [Moles/volume] in Serum or Plasma
111
780
1.43
3.26
4.3
4.9
umol/l
346.2
355.3
0.29
93
666
(3004451) EKG impression Narrative
54
323
1.68
3.25
1.5
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
13
43
3.03
3.24
4.1
2.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
50
294
1.71
3.21
1.4
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
53
317
1.68
3.20
2.0
2.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
47
272
1.73
3.19
1.2
1.2
nmol/l
141.4
134.1
0.35
47
272
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
15
55
2.73
3.15
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
105
737
1.43
3.12
1.3
1.3
pmol/l
295.9
315.0
0.15
82
566
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
9
20
4.50
3.11
5.1
5.6
umol/l
404.8
380.6
—
9
20
(3034426) Prothrombin time (PT)
34
180
1.89
3.08
1.1
1.2
—
—
—
0
0
(4015189)
33
174
1.90
3.03
2.5
2.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
7
12
5.84
3.02
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
35
190
1.85
2.96
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
86
588
1.47
2.95
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
30
155
1.94
2.93
1.5
1.6
ug/l
11.8
8.9
1.32
30
155
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
86
589
1.47
2.93
1.5
1.4
nmol/l
0.3
0.3
0.50
70
452
(3023323) Follitropin [Units/volume] in Serum or Plasma
230
1835
1.26
2.92
1.7
1.3
iu/l
28.5
30.3
0.35
201
1563
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
13
46
2.83
2.91
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
66
428
1.55
2.91
1.2
1.1
mmol/l
33.1
34.6
0.19
59
356
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
23
108
2.13
2.89
1.1
1.1
%
77.4
78.4
—
5
28
(3002523) Influenza virus A Ag [Presence] in Specimen
95
665
1.43
2.89
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
30
156
1.93
2.88
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
15
58
2.59
2.87
2.2
1.5
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
31
164
1.89
2.84
1.4
1.3
%
28.9
22.8
0.54
26
136
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
19
83
2.29
2.83
2.7
1.9
umol/l
19.1
18.0
0.15
19
83
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
182
1417
1.29
2.82
1.9
1.8
iu/l
5.1
4.6
0.20
67
480
(3019977) pH of Arterial blood
58
369
1.58
2.79
2.7
2.6
ph
7.4
7.4
0.40
23
124
(3025549) Creatine [Moles/time] in 24 hour Urine
14
53
2.64
2.79
1.7
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
58
371
1.57
2.73
1.4
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
89
623
1.43
2.73
1.6
1.4
u/l
28.8
30.1
0.12
78
510
(3003740) Influenza virus B Ag [Presence] in Specimen
94
665
1.42
2.72
1.2
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
17
72
2.36
2.72
1.2
1.2
mmol/l
5.7
5.8
—
8
35
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
125
932
1.35
2.65
2.1
1.8
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
26
133
1.96
2.64
1.1
1.1
umol/24h
0.5
0.7
—
7
57
(3013139) Helicobacter pylori Ag [Presence] in Stool
455
3925
1.17
2.63
1.2
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
7
15
4.67
2.59
1.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
14
56
2.50
2.52
8.7
5.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
10
33
3.03
2.52
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
111
820
1.36
2.52
1.1
1.1
iu/ml
200.4
745.0
0.37
20
184
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
11
39
2.82
2.47
1.1
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
35
203
1.73
2.43
1.3
1.5
pmol/l
16.2
15.8
0.16
27
164
(3042517) Benzodiazepines panel - Urine
10
34
2.94
2.41
2.0
2.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
26
138
1.89
2.40
1.9
2.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
83
590
1.41
2.39
3.9
3.0
mg/l
64.4
42.1
0.38
60
438
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1109
10189
1.10
2.38
3.2
3.2
ug/l
0.8
0.8
0.28
780
7100
(3028714) Urate [Moles/time] in 24 hour Urine
5
8
6.25
2.37
1.2
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
651
5810
1.13
2.35
1.9
1.7
%
1.5
1.5
0.60
549
5046
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
13
52
2.50
2.35
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
21
104
2.02
2.35
3.4
3.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
18
84
2.15
2.34
1.1
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
19
91
2.09
2.32
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
363
3112
1.17
2.30
3.6
3.8
u/ml
36.0
71.5
5.13
355
2991
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
29
162
1.79
2.30
1.7
1.3
%
35.9
29.8
0.32
22
106
(3044242) Glucose [Moles/volume] in Arterial blood
52
340
1.53
2.28
1.8
2.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
11
41
2.69
2.27
1.3
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
56
373
1.51
2.26
1.4
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
412
3578
1.16
2.23
1.2
1.2
iu/ml
123.3
138.2
0.37
142
1307
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
237
1966
1.21
2.19
2.3
1.8
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
15
67
2.24
2.17
1.7
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
123
947
1.30
2.16
1.6
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
14
4.29
2.15
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
186
2279
0.81
2.13
1.7
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
99
741
1.34
2.12
1.1
1.1
g/l
1.5
1.5
0.01
91
660
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
47
307
1.53
2.10
1.1
1.1
ratio
1.2
1.1
0.68
17
103
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
8
25
3.20
2.09
2.3
2.2
mg/l
3.6
3.2
—
8
25
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
10
5.00
2.07
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
35
214
1.64
2.05
1.5
1.5
%
4.4
2.5
0.59
30
176
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
139
1.80
2.04
1.1
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
15
69
2.18
2.04
13.1
1.7
mmol/l
7.1
8.0
—
8
34
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
38
238
1.60
2.03
1.9
2.2
umol/l
183.1
132.7
0.17
21
131
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
38
2.63
2.00
1.3
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
63
2.22
2.00
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
574
5142
1.13
1.99
1.7
1.5
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
44
289
1.53
1.94
1.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
64
2.19
1.94
1.5
1.3
—
—
—
0
0
(44813793)
51
346
1.48
1.93
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
48
322
1.49
1.92
2.5
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
27
157
1.72
1.92
1.3
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
28
165
1.70
1.90
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
8
28
2.86
1.86
1.1
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
28
2.86
1.86
1.3
1.6
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
23
129
1.79
1.85
3.0
2.8
ng/l
109.1
155.7
0.50
14
60
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
46
2.39
1.85
1.1
1.2
u/l
7.0
17.2
0.98
11
46
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
921
8497
1.10
1.84
1.4
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
12
53
2.27
1.80
1.1
1.2
u/ml
1.5
0.8
—
6
31
(40762365) Oxygen content in Arterial blood by calculation
19
101
1.88
1.80
1.9
2.9
ml/dl
15.3
14.7
0.49
19
93
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
91
693
1.32
1.78
1.1
1.1
u/ml
3.6
3.0
0.19
18
280
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
6
18
3.33
1.74
1.0
1.0
u/ml
0.3
0.6
—
6
12
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
18
3.33
1.74
1.2
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
62
447
1.39
1.73
1.7
1.4
ug/l
2.3
4.2
2.17
55
379
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
24
2.92
1.72
2.6
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
13
3.85
1.71
1.2
1.3
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
5
13
3.85
1.71
5.2
5.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
90
1164
0.77
1.70
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
179
1.62
1.69
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
450
4021
1.13
1.67
1.3
1.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
8
31
2.58
1.65
1.1
1.5
umol/24h
317.1
330.8
—
8
31
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
21
119
1.77
1.65
5.7
3.6
u/l
22.3
41.4
—
6
37
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
284
2462
1.16
1.65
2.4
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
35
228
1.54
1.64
1.4
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
38
253
1.50
1.62
1.5
1.7
nmol/l
7.5
6.4
0.08
28
209
(43055514) Macroprolactin [Presence] in Serum or Plasma
18
98
1.84
1.61
1.4
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
12
56
2.14
1.61
2.8
2.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
26
2.69
1.58
1.3
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
13
64
2.03
1.53
1.3
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
37
2.43
1.47
1.8
2.6
—
—
—
0
0
(3025315) Body weight
9
37
2.43
1.47
5.1
4.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
17
94
1.81
1.47
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
38
2.37
1.45
1.1
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
38
2.37
1.45
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
74
567
1.31
1.45
1.6
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
194
1654
1.18
1.43
1.7
1.9
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
9
39
2.31
1.42
1.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
31
204
1.52
1.42
3.3
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
31
204
1.52
1.42
3.4
2.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
88
1.82
1.41
1.6
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
213
0.52
1.41
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
45
321
1.40
1.39
2.2
2.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
14
74
1.89
1.38
11.5
11.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
96
1.77
1.38
2.1
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
157
1319
1.19
1.38
2.7
3.1
u/ml
232.0
720.4
1.07
139
1195
(3025130) Human papilloma virus identified in Specimen
81
634
1.28
1.37
2.2
1.7
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
30
198
1.52
1.37
3.2
2.7
umol/l
27.6
28.9
0.20
22
143
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
23
2.61
1.36
9.5
7.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
33
223
1.48
1.35
1.0
1.0
%
100.3
92.0
0.63
27
166
(40762814) Titanium [Mass/volume] in Blood
19
112
1.70
1.35
2.1
2.2
ug/l
4.3
3.8
0.12
12
41
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
120
1.67
1.33
1.2
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
35
242
1.45
1.29
2.5
2.2
umol/l
68.4
54.7
1.04
22
193
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
48
2.08
1.27
1.3
1.1
—
—
—
0
0
(4212803)
12
62
1.94
1.27
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
50
370
1.35
1.27
2.3
1.4
g/l
0.9
0.9
0.39
50
370
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
67
518
1.30
1.26
4.5
4.7
u/ml
178.3
87.1
0.25
17
146
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
45
2.00
1.23
1.8
1.5
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
9
45
2.00
1.23
1.0
1.1
—
2.9
—
0
8
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
5
19
2.63
1.21
3.4
4.4
mg/l
5.0
3.3
—
5
11
(3043410) Blood group antigens tested for on Red Blood Cells
25
164
1.53
1.20
1.8
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
145
0.48
1.19
1.4
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
39
281
1.39
1.18
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
20
125
1.60
1.17
1.4
1.6
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
23
151
1.52
1.11
1.3
1.3
nmol/l
161.3
123.2
0.68
16
104
(3028707) Methadone [Presence] in Urine by Screen method
79
636
1.24
1.11
2.5
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
647
6030
1.08
1.10
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
112
937
1.20
1.09
1.8
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
40
294
1.36
1.09
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
41
1.95
1.08
1.1
1.2
—
—
—
0
0
(4146454)
84
684
1.23
1.07
2.8
2.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
16
97
1.65
1.06
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
129
1509
0.85
1.04
1.5
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
21
139
1.51
0.99
6.5
7.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
20
131
1.53
0.99
1.1
1.3
mu/l
45.6
69.7
—
9
97
(3023487) Leukocytes [#/volume] in Peritoneal fluid
30
214
1.40
0.99
3.7
2.1
e6/l
559.8
4417.0
0.54
23
148
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
9
49
1.84
0.98
1.2
1.6
nmol/l
3.9
4.6
—
9
49
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
55
694
0.79
0.97
1.3
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
27
190
1.42
0.96
3.4
1.9
e6/l
5233.2
23839.8
1.02
12
105
(40768793) Breast Pathology biopsy report
162
1416
1.15
0.96
1.3
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
16
247
0.65
0.95
1.0
1.1
u/ml
1.0
0.9
—
7
80
(3005033) Fetal Nuchal fold Thickness US
55
692
0.79
0.95
1.3
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
25
174
1.44
0.94
3.0
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
87
724
1.20
0.93
1.4
1.3
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
6
27
2.22
0.93
2.3
1.7
mmol/l
26.2
15.7
—
6
21
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
20
134
1.49
0.91
5.0
2.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
42
322
1.31
0.90
2.5
1.8
u/field
1.3
2.8
1.23
33
222
(3011288) Drugs identified in Urine by Screen method
113
966
1.17
0.90
4.5
3.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
10
56
1.79
0.87
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
23
161
1.43
0.86
1.7
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
58
715
0.81
0.86
1.4
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
18
120
1.50
0.85
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
41
318
1.29
0.83
2.2
2.1
ug/min
27.1
194.9
—
9
77
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
238
0.67
0.83
1.0
1.0
u/ml
5.6
0.4
—
9
60
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
8
46
1.74
0.82
2.3
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
21
296
0.71
0.82
1.2
1.3
—
1.5
—
0
22
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
18
122
1.48
0.80
1.4
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
10
58
1.73
0.79
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
71
846
0.84
0.77
1.4
1.4
—
—
—
0
0
(44806420)
28
208
1.35
0.77
2.3
2.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
71
845
0.84
0.76
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
78
660
1.18
0.74
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
24
2.08
0.74
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
65
541
1.20
0.74
2.9
2.1
u/field
1.7
2.1
0.32
23
198
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
71
842
0.84
0.74
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
45
360
1.25
0.74
5.9
6.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
18
125
1.44
0.72
1.1
1.2
umol/l
18.4
16.9
0.80
18
111
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
72
845
0.85
0.68
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
153
1375
1.12
0.65
4.2
3.6
mg/l
26.1
27.7
0.25
94
866
(3038071) Oxygen [Partial pressure] in Mixed venous blood
17
120
1.42
0.64
6.2
7.9
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
29
1.72
0.64
1.2
1.1
—
—
—
0
0
(4024509)
76
653
1.17
0.63
1.7
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
34
269
1.27
0.63
1.1
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
23
172
1.34
0.63
2.2
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
127
1133
1.12
0.62
2.3
2.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
15
209
0.72
0.59
1.0
1.0
u/ml
1.5
2.8
—
6
31
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
38
1.58
0.54
3.8
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
68
779
0.87
0.51
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
145
1331
1.09
0.46
2.2
2.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
76
854
0.89
0.45
1.1
1.1
u/ml
2.5
1.7
0.20
41
322
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
57
652
0.87
0.44
1.5
1.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
31
1.61
0.43
1.4
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.8
1.4
pmol/l
42.6
24.7
—
5
24
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
32
1.56
0.42
4.0
3.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
24
194
1.24
0.41
1.8
2.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
18
141
1.28
0.40
1.1
1.2
pmol/l
236.0
277.3
0.26
12
101
(3022475) Manganese [Moles/volume] in Blood
5
35
1.43
0.39
1.6
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
39
334
1.17
0.39
5.4
13.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
74
664
1.12
0.39
2.6
1.9
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
5
36
1.39
0.38
2.8
3.5
—
0.0
—
0
6
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
51
448
1.14
0.37
2.0
2.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
74
819
0.90
0.36
1.7
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
153
1427
1.07
0.36
2.2
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
84
923
0.91
0.36
1.4
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
47
412
1.14
0.36
1.4
1.5
promille
1.5
1.1
1.02
39
316
(3005011) Chlamydia sp Ab [Titer] in Serum
11
81
1.36
0.36
2.6
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
55
489
1.13
0.35
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
83
758
1.10
0.33
1.9
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1817
18451
0.98
0.32
3.3
3.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
176
0.80
0.32
1.6
1.9
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
119
1.26
0.31
1.6
1.5
%
18.1
7.8
—
7
60
(4211845)
28
326
0.86
0.31
4.3
3.6
—
—
—
0
0
(4094501)
164
1547
1.06
0.30
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
27
231
1.17
0.29
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
153
1443
1.06
0.29
2.2
2.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
17
206
0.82
0.29
1.5
1.5
—
—
—
0
0
(4198724)
21
176
1.19
0.28
2.3
2.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
26
301
0.86
0.27
1.5
1.4
pmol/l
161.2
151.0
—
7
91
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
72
1.25
0.25
2.2
2.5
u/field
0.7
0.6
—
9
72
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
32
282
1.14
0.25
1.5
1.6
mmol/l
8.6
8.0
0.45
24
173
(3041806) Other cells [#/volume] in Blood by Manual count
15
123
1.22
0.25
1.6
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
105
1.24
0.24
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
87
1.26
0.24
1.7
3.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
151
1436
1.05
0.23
2.2
2.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
47
427
1.10
0.23
2.0
1.9
ug/l
6.6
3.9
0.38
42
373
(3014133) Dog dander IgE Ab [Units/volume] in Serum
52
568
0.91
0.23
1.1
1.1
u/ml
4.5
2.8
0.51
25
210
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
37
332
1.11
0.23
1.1
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
181
1733
1.05
0.22
1.3
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
45
410
1.10
0.22
1.1
1.0
ng/l
237.8
336.8
3.23
32
276
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
43
472
0.91
0.21
1.1
1.0
u/ml
0.7
0.3
0.40
18
116
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.21
0.0
5.5
—
60.7
—
0
10
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
45
411
1.10
0.21
1.1
1.0
ng/l
762.2
703.9
0.37
31
267
(3036071) Salmonella sp Ab [Titer] in Serum
20
173
1.16
0.20
1.1
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
48
1.25
0.20
1.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
45
413
1.09
0.19
1.1
1.0
ng/l
33.5
44.8
1.58
30
274
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
48
446
1.08
0.16
1.3
1.3
mmol/l
13.0
11.8
0.34
23
107
(3025577) Chromium [Mass/volume] in Blood
45
417
1.08
0.16
2.2
2.0
ug/l
3.1
2.4
0.42
39
351
(3027944) Amphetamines [Presence] in Urine
147
1415
1.04
0.16
2.1
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
27
298
0.91
0.16
4.4
3.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
20
177
1.13
0.16
1.3
3.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
47
439
1.07
0.15
1.5
2.1
mmol/l
6.1
6.7
1.44
33
296
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
163
1684
0.97
0.14
1.6
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
93
1.18
0.14
6.6
7.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
22
242
0.91
0.13
1.1
1.0
u/ml
37.1
5.0
—
6
34
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
172
1769
0.97
0.12
2.0
1.7
mg/l
6.7
3.5
1.37
132
1271
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
123
1.14
0.12
1.1
1.0
—
—
—
0
0
(4281824)
67
702
0.95
0.12
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
20
182
1.10
0.11
1.2
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
63
604
1.04
0.10
1.4
1.2
nmol/l
325.7
342.9
0.30
50
485
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
46
1.09
0.09
1.0
4.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
287
2825
1.02
0.09
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
73
756
0.97
0.09
1.1
1.1
u/ml
8.5
4.3
1.04
47
373
(3008401) Mugwort IgE Ab [Units/volume] in Serum
70
725
0.97
0.08
1.1
1.1
u/ml
4.7
1.1
0.85
40
303
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
57
1.05
0.08
1.2
1.1
umol/24h
1.4
1.7
—
6
57
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
189
1854
1.02
0.08
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
36
379
0.95
0.08
1.3
1.2
—
—
—
0
0
(44806071)
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
71
0.84
0.07
2.3
2.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
84
1.07
0.07
1.2
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
452
1.04
0.07
1.4
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
105
1073
0.98
0.06
1.4
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
13
119
1.09
0.06
6.5
6.9
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
129
1.09
0.05
1.1
1.1
u/ml
1.6
1.9
—
9
65
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
20
212
0.94
0.05
1.4
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
65
663
0.98
0.03
1.1
1.1
u/ml
1.0
2.5
1.60
22
157
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
70
713
0.98
0.03
1.4
1.3
mmol/l
7.6
7.5
0.09
49
521
(4133840)
12
114
1.05
0.00
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
12
116
1.03
0.00
1.7
1.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
137
1.02
0.00
1.7
2.3
mmol/l
7.0
7.4
—
9
81
(3023430) Cat dander IgE Ab [Units/volume] in Serum
52
523
0.99
0.00
1.1
1.1
u/ml
4.0
4.1
0.02
25
203
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
76.6
—
0
6
(3015350) Toxocara sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.4
—
0
6
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
80
1.00
0.00
4.5
6.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
89
0.90
0.00
1.3
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
76
0.92
0.00
2.1
2.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
137.2
—
0
9
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
38.2
—
0
5
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
80
1.00
0.00
2.3
3.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
2.7
—
0
5
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
7.8
—
0
5
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_ZOSTER and mortality.

Females

Parameter HR [95% CI] p-value
AB1_ZOSTER 1.44 [1.31, 1.58] < 0.001
Birth year 0.992 [0.98, 1.0] 0.045

During the follow-up period (1.1.1998 — 31.12.2019), 7716 out of 24100 females with AB1_ZOSTER died.

Males

Parameter HR [95% CI] p-value
AB1_ZOSTER 1.591 [1.42, 1.78] < 0.001
Birth year 0.989 [0.98, 1.0] 0.012

During the follow-up period (1.1.1998 — 31.12.2019), 4984 out of 15694 males with AB1_ZOSTER died.

Mortality risk

Mortality risk for people of age

years, who have AB1_ZOSTER.

N-year risk Females Males
1 0.103% 0.298%
5 0.668% 1.907%
10 1.762% 4.73%
15 3.41% 8.624%
20 6.301% 14.794%

Relationships between endpoints

Index endpoint: AB1_ZOSTER – Zoster [herpes zoster]

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data